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1. INTRODUCTION 
 
1.1 THE HERPESVIRIDAE’S FAMILY TAXONOMY 
 
Herpesviruses are large DNA-containing enveloped viruses widely distributed in 
nature. Based on biological properties and sequence data, the family 
Herpesviridae is divided into three subfamilies Alpha-, Beta-, and 
Gammaherpesvirinae [1,2,3,4].  
Alphaherpesvirinae (containing Simplexviridae, Varicelloviridae, Mardiviridae 
and Iltoviridae genera) were classified by a variable host range, short 
reproductive cycle, rapid spread in tissue colture and ability to establish latent 
infections primarily in sensory ganglia. The known human pathogens of this 
subfamily are: herpes simplex virus 1 and 2 (HSV-1, HSV-2) and varicella 
zoster virus (VZV). 
Betaherpesvirinae (containing Cytomegaloviridae, Muromegaloviridae and 
Roseoloviridae) were characterized by a limited host range, long reproductive 
cycle and slow infection progression in tissue culture. Cells that are infected 
often become enlarged (cytomegalia) and the virus can maintain latency in 
secretory glands, lymphoreticular cells, kidneys and other tissues. The human 
herpesviruses members of this subfamily are: human cytomegalovirus (HCMV 
or HHV-5), human herpesviruses 6A,  6B and 7 (HHV-6A, HHV-6B, HHV-7). 
Gammaherpesvirinae is divided into two genera: Lymphocryptoviridae which 
includes human Epstein-Barr virus (EBV or HHV4) and Rhadinoviridae which 
includes human Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV8). 
They were classified by a very limited host range, actually they are usually 
specific for T and B cells and establish a latent infection in lymphoid tissues. 
All members of the Herpesviridae family share the same virion structure, 
genomic arrangement and biological properties. 
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1.2 HERPES SIMPLEX VIRUS (HSV-1) 
  
1.2.1 Epidemiology and Pathogenesis  
Herpes simplex virus type 1 infects 60%-80% of people throughout the world. 
Initial HSV infection usually happens in childhood and is often asymptomatic 
[5]. Virus transmission occurs between an infected human to a susceptible one, 
by close contact. The oropharyngeal mucosa is the most common location of 
primary infection,  but incident episodes of genital infection by HSV-1 seems to 
be increased [6,7]. Generally HSV infections are confined to skin and mucosa 
but could be severe in immunocompromised host. HSV-1 causes oral, labial and 
occasionally facial lesions, it may cause keratitis if infects the eye mucosa and is 
the most common cause of sporadic encephalitis in adults Fig. 1.2. A [5].  
 
 
Fig. 1.2.A Sites of HSV infection and disease [5]. 
 
During primary infection, HSV-1 replicates at the site of entry then infects nerve 
endings and translocates by retrograde transport to the nuclei of sensory ganglia 
[8] Fig 1.2.B. In the majority of the infected neurons, the viral genome remains 
for the entire life of the host in an episomal state. In some individuals, the virus 
reactivates and is moved by anterograde transport to a site at or near the portal 
of entry. Recurrences are spontaneous, but there is an association with physical 
or emotional stress, fever, exposure to ultraviolet light, tissue demage and 
immune suppression  
• Primary genital herpes 
(HSV-2 or HSV-1) 
•Recurrent herpes 
• Primary HSV-1 
oropharyngeal herpes 
• Recurrent labialis 
Neonatal herpes 
• Mucocutaneous disease  
(immunocompromised 
host) 
• Encephalitis 
• Keratitis 
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Fig. 1.2.B (a) Primary infection. (b) Recurrent infection. [8] 
 
1.2.2 Structure 
Herpesvirus particles consist of four morphologically distinct structures: an 
electron-dense toroidal core, a highly ordered  icosahedral-shape capsid, an 
amorphous tegument and an outer envelope containing glycoprotein spikes [9] 
(Fig. 1.2.C). 
The core contains a copy of linear double-stranded DNA closely packed into 
multiple shells [10].  
The capsid, about 125-130 nm in diameter, is an icosahedron with 150 
hexameric and 12 pentameric capsomers, which are connected in groups of three 
by the triplexes (asymmetric structures). The hexons consist of six molecules of  
the major capsid protein (MCP or VP5, UL19 gene product) together with six 
molecules of the smallest capsid protein (SCP or VP26, UL35 gene product). 
Eleven pentons consist of five MCP molecules and the other one is compound 
by twelve molecules of the portal protein (PORT, UL6 gene product). The 
triplex consist of  two copies of the triplex dimer protein (TRI2 or VP23, UL18 
gene product) and one copy of the triplex monomer protein (TRI1 or VP19C 
UL38 gene product) [11]. 
The tegument is a proteinaceus layer which contains more than 20 virus-
encoded proteins important in various aspects of the virus life cycle [12] . 
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Fig. 1 2.C. Herpes virus structure. On the left image of HSV obtained at electron microscopy. 
On the right, Herpesvirus capsid at 8 Å resolution [11] surrounded by representation of HSV layers. One of 
triangular faces is denoted by black triangle. 
 
The most notable proteins include the α-trans-inducing factor (α-TIF or VP16) 
which induces the transcription of viral immediate-early genes and the virion 
host shut-off protein (vsh) that degrades most of the host mRNAs during the 
initial stage of infection. 
The HSV envelope contains at least eleven glycoproteins (gB, gC, gD, gE, gG, 
gH, gI, gJ, gK, gL and gM). Additional membrane proteins not detected in 
virion envelope are UL20, UL34, UL45 and possibly US9. At the ultrastructural 
level, HSV glycoproteins form long thin spikes, each made of a single species. 
The envelope contains 600-750 glycoprotein spikes that vary in length and in the 
angle at which they emerge from membrane. The distribution suggests 
functional clustering [13]. 
 
1.2.3 HSV-1 genome, organization, replication and transcription 
The HSV-1 genome is approximately of 150 kbp with a G+C content of 68%. 
The genome consists of two unique sequences, designated as L (long) and S 
(short), bracketed by inverted repeats of different lenghts named ab and b’a’ for 
the L component and a’c’ and ca for the S one. 
The genome can be represented as follows: 
   aLanb-UL-b’a’mc’-US-caS
where the a sequence can be variable. 
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By the inversion of one or both unique sequences four different isomers are 
originated, these isomers may be purified in equimolar amount from infected 
cells [14].  
The HSV-1 genome encodes for about 90 transcriptional units, and for 84 
different gene products [12]. The majority of HSV genes encode for a single 
protein. Many mRNAs initiate in the middle of an expressed ORF and encode 
only the C-terminal part of the protein. Few transcripts do not appear to encode 
expressed ORFs and their function in productive infection is not known e.i. the 
latency-associated transcripts (LATs) which are expressed in latent infection 
[14]. 
The genes of HSV-1 are divided into three classes, according to their kinetic 
expression after virus entry: α, or immediate early genes, that map near the 
termini of the L and S components, with the exception of α0 and α4 that map in 
the inverted repeats sequences; β, or early genes, and γ, or late genes, 
disseminated long the L and S sequences. 
Viral DNA is replicated by the rolling-circle mechanism in the nucleus of the 
host cell forming concatameric molecules which become cleaved into individual 
units during their packaging into capsids. At least three virus-encoded gene 
products are required for viral DNA synthesis: the viral DNA polymerase, the 
single-stranded DNA-binding protein (ICP8), and the origin-binding protein 
UL9. The origins of DNA synthesis oriS and oriL, made of palindromic 
structures, carry a binding site for UL9. UL9 has an ATP-binding and DNA 
helicase motifs, essential for viral replication. The binding of UL9 induces a 
bend in the DNA so it forms a single-stranded stem loop structure, and thus 
ICP8 is recruited. The remaining viral DNA replication proteins, as viral DNA 
polymerase, are recruited to the replication fork and the viral DNA synthesis 
initiates. 
Viral DNA is transcribed by host RNA polymerase II and gene expression is 
tightly regulated in a cascade fashion (Fig. 1.2.D).  
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Sequence analysis of the LAT domain showed the presence of at least 16 ORFs, 
two of which, ORF O and ORF P, play some roles. Thus ORF O and ORF P 
gene products are expressed from a single mRNA, such that they share the same 
amino-terminal sequence and then diverge. Protein encoded by ORF O binds 
ICP4 and prevents the transcription of HSV DNA. ORF P protein product co-
localizes with spliceosomes and reduces the accumulation of ICP0. 
 
  
 
Fig 1.2.E HSV establishment of latency. In productive infection, HSV enters at mucosal surfaces, replicates in 
epithelial cells at the site of entry and spreads through the tissue. Virus enters nerve endings of sensory neurons 
and is transported to neuron cell body in the ganglion where virus can either replicate productively or establish a 
latent infection: viral DNA 
 
 
1.3 VIRUS MEMBRANE FUSION 
 
Enveloped viruses like HSV enter cell via fusion of their membrane with a host 
cell membrane. Virus membrane fusion can occur either at the plasma 
membrane or at an intracellular location following internalization of virus by 
receptor-mediated endocytosis. Membrane fusion is energetically unfavorable 
and does not spontaneusly occur. According to the stalk hypothesis, fusion of 
two lipid bilayers in an aqueous enviroment requires that they come into close 
contact. This process involves local membrane bending creating a first site of 
contact. Two forces dominate, a repulsive hydration force arising from water 
tightly bound to the lipid headgroups, and an attractive hydrophobic force 
between the hydrocarbon interiors of the membrane. Dehydration of the initial 
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contact site induces monolayer rupture that allows mixing of lipids from the two 
outer leaflets, resulting in a hemifusion stalk in which the aqueous inner 
contents remain distinct. In a next step the radial expansion of the stalk leads to 
either direct fusion pore opening or to the formation of another intermediate, the 
hemifusion diaphragm, a local bilayer resulting from the contact between the 
two internal leaflets of the fusing membranes. The break of the hemifusion 
diaphragm also result in pore formation. Finally, pore enlargement, leads to 
complete fusion (Fig. 1.3.A),[15]. In virus entry the energy necessary for 
membrane deformation and bending is provided by glycoproteins called fusion 
proteins. Upon appropriate triggering, the fusion protein interacts with the target 
membrane through a hydrophobic fusion peptide and undergoes a 
conformational change that drives the membrane fusion reaction. There are a 
variety of fusion triggers, including various combinations of receptor binding, 
receptor/coreceptor binding and exposure to the midly acidic pH within the 
endocytic pathway. 
Three different classes of viral fusion proteins have been identified based on 
their important structural features. 
 
Fig. 1.3.A Fusion-through-hemifusion. The proximal and distal 
leaflets of the membrane at the top are labeled with purple and 
blue. In the initial prefusion state (1), membranes are separated 
by an approximately 10 nm gap determined by the size of the 
membranedocking proteins. (2) Proteins bring membrane 
bilayers into close contact. For simplicity, the proteins are not 
shown at the periphery of the contact zone. (3) The proximal 
leaflets merge into a fusion stalk, which allows lipid mixing 
between these leaflets, provided that the lipid flow is not 
hindered by proteins surrounding the fusion site. (4) The stalk 
expands into a hemifusion diaphragm that either breaks to form a 
fusion pore allowing lipid and content mixing (5) or dissociates, 
yielding separated membranes and interrupting fusion at the stage 
detectable as complete or partial lipid mixing between the 
proximal membrane leaflets (6). 
 
 
1.3.1 Class I fusion proteins 
The haemagglutinin protein from influenza virus has provided the model for 
class I fusion machines, because the atomic structure of three different forms of 
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this protein have been determined. The class I model, in its essential features, 
applies to proteins of many unrelated virus families as the HIV gp120, the F 
proteins from paramyxoviruses, the retroviral SU/TM proteins and the Ebola 
virus Gp2 protein. 
These proteins are homotrimers that project vertically from the virus membrane 
and contain mostly α-helical structures. They form trimers both before and after 
the fusion reaction. Type I fusion proteins are frequently synthetized as a single-
chain precursor which undergoes cleavage by host proteases. The cleavage 
generates an N-terminal globular protein and a metastable C-terminal protein. 
The novel N-terminus contains a hydrophobic sequence (15-30 amino acids), 
known as “fusion peptide”. Downstream of it, it’s possible to recognise at least 
two HR (heptad repeat) regions: one adjacent to the fusion peptide called HR-N 
and one close to the original trasmembrane domain, called HR-C. After binding 
to a receptor or exposure to the low pH, the protein forms an extended 
conformation, in wich HR-N form a trimeric coiled coil, and the fusion peptides 
insert into the target membrane.Then HR-C fold over the hydrophobic grooves 
of HR-N trimer in anti parallel direction, thus forming a trimer of hairpins 
containing a central α-helical coiled-coil structure. In this new conformation the 
fusion peptide and the original transmembrane domain are juxtaposed. As a 
consequence, the viral envelope and the target membrane are close (Fig. 1.3.B). 
The transition from the metastable conformation to the final stable conformation 
provides the energy necessary for the fusion process, but for many proteins 
seems that the energy released by the refolding of one trimer is not sufficient. 
Some observations suggest that the density of influenza virus hemagglutinin is 
important for fusion and a decrease arrests fusion at hemifusion stage. In 
contrast to HA, data on HIV-1 env suggest that a single env trimer is sufficient 
for fusion. On the other hand cellular receptor density, as well as env density, 
affect the kinetics of HIV-1 env mediated fusion [16]. 
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Cell membrane 
 
Viral envelope 
Fig. 1.3.B (from [17]). Proposed mechanism for membrane fusion by class I fusion proteins. a) The metastable 
conformation of a trimeric generalized fusion protein,with helical domain A in orange, helical domain B in pink, 
and the transmembrane domain in purple. b) After binding to a receptor on the cellular membrane, or on 
exposure to the low pH found in intracellular compartments, the protein forms an extended conformation and the 
hydrophobic fusion peptide (red) inserts into the target membrane. c) Several trimers are thought to be involved. 
d) Protein refolding begins. The free energy thereby released causes the membranes to bend towards each other. 
e) Formation of a restricted hemifusion stalk allows the lipids in the outer leaflets of the membranes to mix. f) 
Protein refolding completes, forming the final, most stable form of the fusion protein,with the fusion peptide and 
TM domain anti-parallel to each other but in the same membrane. 
 
1.3.2 Class II fusion protein 
Representative members of class II fusion protein are the E proteins of the 
flavivirus tick-borne encephalitis virus (TBE) and dengue virus (DV) and the E1 
protein of the alphavirus Semliki Forest virus (SFV) [17-18]. 
The type II fusion proteins form heterodimers  with a regulatory membrane 
protein maturated by the cellular furin enzyme; in flavivirus, the maturation of 
the regulatory protein leads the heterodimers to reorganize in homodimers. For 
both alphaviruses and flaviviruses, furin processing of the companion protein is 
an important regulatory step without which the virus has decreased infectivity. 
The dimer of class II fusion proteins do not form spikes but are parallel to the 
viral membrane. These proteins are elongated finger like molecules with three 
globular domains composed almost entirely of β-sheets; they are not 
proteolytically activated. They carry an internal fusion peptide in a loop between 
two-β-strands. Low pH dissociates the dimers and exposes the fusion loop, than 
the proteins reorient vertically, insert into the target membrane and trimerize. 
Structural predictions suggest that the fusion loop insert only peripherally into 
the bilayer, projecting their aromatic side chains into the aliphatic region of the 
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outer leaflet of the target membrane. After the trimerization a further 
rearrangement bring the original transmembrane domain juxtaposed to the 
fusion peptide thanks to a flexible region, adjacent to the trasmembrane domain 
called stem region. The type II fusion proteins are not predicted to form a coiled 
coil, their post-fusion state is characterized by trimers of hairpins composed of 
beta structures (Fig. 1.3.C).   
 
  
 
Fig. 1.3.C (from [17]) Proposed mechanism for fusion by class II proteins, a) The dimeric E protein binds to a 
cellular receptor (grey) and the virus is internalized to endosomes. Membrane fusion,which will release the virus 
into the body of the cell, takes place within endosomes. Domain I is in red, domain II in yellow, and domain III 
in light and dark blue (the lighter blue shows a predicted but unsolved structure). b) The acidic pH inside 
endosomes causes domain II to swing upward, permitting E monomers to rearrange laterally. c) The fusion loop 
(red dot) inserts into the outer leaflet of the host-cell membrane, enabling trimer formation. d) The formation of 
trimer contacts extends from the top to the bottom of the molecule. Domain III shifts and rotates to create 
contacts, bending the membrane. e) The formation of further contacts leads to unrestricted hemifusion. f) The 
final most stable form of the protein. 
 
1.3.3 Class III fusion protein 
The distinct structural features of vescicular stomatitis virus (VSV) glycoprotein 
(G) from class I and II have resulted in the creation of a third class of fusion 
protein, class III. In this class are also enclosed proteins of other Rhabdoviridae 
and gB of HSV. The VSV G protein oligomerizes into a homotrimer during the 
transport to the cell surface and is not subject to proteolytic priming for fusion 
activation. G forms spikes that protrude from the viral surface, it is responsible 
for viral attachment to specific receptors and for membrane fusion after 
endocytosis of the virion. Unlike  the other two type of fusion protein G have 
not an irreversibile metastable pre-fusion state. The VSV G conformational 
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change induced by its exposure to low pH in endosomes is reversible. G can 
adopt at least three conformational states: the native pre-fusion state detected at 
the viral surface above pH 7 (Fig 1.3.D); the activated hydrofobic state, which 
interacts with the membrane as a first step of the fusion process; finally the 
fusion–inactive post-fusion conformation that is antigenically distinct from the 
other two. The post-fusion conformation displays the classic hairpin 
conformation of other viral fusogenic proteins, that is an elongated structure 
with the fusion domain and the TM domain at the same end of the molecule. As 
in class I fusion proteins, the post-fusion trimer displays a six-helix bundle with 
the fusion domains at the N terminus of the central helices and the TM domains 
at the C-terminus of the antiparallel outer helices. However, each fusion domain 
exposes two fusion loops located at the tip of an elongated β-sheet revealing a 
striking convergence with class II fusion proteins [19-20]. It isn’t clear how 
VSV G catalyzes the fusion process, it has been proposed that a concerted 
cooperative change of a large number of glycoproteins, perhaps organized in a 
hexagonal lattice, is used to overcome the high energetic barrier encountered 
during fusion. 
 
 
 
 
 
 
 
 
Fig. 1.3.D a) View of the G protomers structures in pre- and postfusion conformations, colored by domain. b) 
View of corresponding G trimers. C) Domain architecture of VSV G plotted on a linear diagram with domain 
boundaries numbered. [20] 
a) b)
c)
 
1.4 HSV ENTRY INTO HOST CELLS 
The current model of HSV-1 entry consists of  three stages: the first step 
involves virus attachment to the cell surface, the second step involves the 
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interaction of glycoprotein D (gD) with an entry receptor, and the third step 
involves fusion of the viral envelope with the host membrane followed by 
releasing of the capsid-tegument complex into the cytoplasm of the infected cell, 
or involves endocitosys followed by fusion with endosomal membrane. The site 
of entry is cell type dependent, but in both cases the fusion is driven by four 
essential glycoprotein gD, gB, gH and gL. 
 
1.4.1 The attachment 
The attachment of the virus to cell membranes is mediate by gC (non essential 
glycoprotein encoded by UL44 gene), and possibly gB, which interact with 
glycosaminoglycans (GAGs) [21]. The attachment is reversible, ensures that 
virions are tethered and concentrated on the cell surface but even if enhances 
infectivity by approximately 10 fold, is not strictly required. 
Some reports have suggested that three different pathways are implicated in 
HSV-1 entry into different cell types: via direct fusion with the plasma 
membrane, via fusion within an acidic or a neutral endosome [22-24]. 
Furthermore in each pathways are required gD, gB, gH, gL and a gD receptor.  
 
1.4.2 Receptors 
gD interacts with three alternative entry receptors, nectin1, HVEM (herpesvirus 
entry mediator, also named HveA for herpesvirus entry mediator A) and specific 
O-sulphated (3-O-S) moieties on HS generated by the enzymatic activity of 
certain D-glucosaminyl O-sulfotransferases on HS [25-30]. 
The three receptors belong to structurally unrelated molecular families [30-32]. 
HVEM belongs to the tumor necrosis factor receptor (TNFR); it seemed to be 
restricted to T-lymphocytes in human tissues, but  its distribution may be wider, 
at least as judged from cultured cells. The interaction with gD involves two of 
the four typical cysteine-rich domains (CRD) of TNFRs.  Like other TNFRs, 
HVEM has in the cytoplasmic tail a death domains or TRAF (TNFR-associated 
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factor) interacting motifs with which may trigger intracellular transduction 
pathways.  
Nectin1 belongs to a family of intercellular adhesion molecules, whose 
ectodomain is made of three immunoglobulin (Ig)-structured domains. Nectins 
mediate cell adhesion by forming cis-homodimers (e.g. nectin1-nectin1) on the 
cell surface, and trans-dimers with other nectins located on adjacent cells. 
Trans-dimers are formed between nectins of the same molecular species, but 
also between nectins belonging to different species (e.g. nectin1 to nectin3), in 
highly specific associations.  Nectin1 is broadly expressed in human tissues, 
including tissues and organs targeted by HSV, like CNS, ganglia and muco-
epithelia [33-37] and is expressed in virtually all human cell lines [31-32]. 
3-O-sulfated Hepara Sulfate derived from heparan sulfate proteoglycans 
modified by the enzymatic activity of certain D-glucosaminyl O-
sulfotransferases which are present in a number of human cells, including 
neuronal and endothelial cells, and corneal fibroblasts. There is limited 
information regarding the interaction of HSV with 3-O-S HS. 
It is unclear why HSV interacts with multiple alternative receptors. The gD 
affinity to nectin1 and HVEM is of the same order of magnitude (10-6 M); hence, 
affinity is not a basis for preferential usage [38]. Because clinical isolates use 
both nectin1 and HVEM, it appears that this property favours successful 
infection and spread in the human host [39].  
A type 2 glycoprotein, designated B5, was identified by its ability to render 
otherwise resistant porcine cells more susceptible to HSV entry [40]. The same 
cells were rescued by HVEM, and it was thus proposed that B5 serves as HSV 
receptor. However, the ability of B5 to bind virions, or, even more so, a specific 
glycoprotein was not documented.  
Recent data suggest, that also gB may interact with an own receptor on the cell 
surface. Thus a soluble truncated form of  gB is able to bind in a saturable manner 
to the surface of different cell types, including cells deficient in heparan sulfate 
proteoglycan or even after heparin treatment to remove gB bound to HS.  Besides 
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the soluble gB inhibits HSV-1 entry into HS deficient cells in a dose-dependent 
manner. The nature and the role in the entry of HSV-1, of this receptor is still 
unknown [41]. A molecule that associate with gB and seems to serve as co-
receptor in HSV-1 entry may be PILR (paired immunoglobulin-like type 2 
receptor) [42]. 
1.4.3 HSV fusogenic glycoprotein 
1.4.3.1 gD 
HSV-1 glycoprotein D is a type I membrane glycoprotein of 369 aa, after signal 
sequence cleavage, with a single transmembrane segment located between aa 
317 and 339 (fig. 1.4.A) and three glycosylation sites. 
The crystal structure of a soluble form of gD (up to aa residue 259) alone or in 
complex with the ectodomain of HVEM was solved [43]. 
gD’s ectodomain structurally consists of three regions: the central core consist in 
a V-like domain of the immunoglobulin fold (residues 56-184) and a 17 aa long 
helix; the N-terminus (residues 1-37), that is unstructured in the crystal of gD 
alone, but forms a hairpin (bending at residue 21) in the crystal of the complex 
with HEVM; the C-terminus folds back towards the N-terminus [44].  
The contacts of gD for HVEM have been localized within the N-terminal hairpin 
[43; 45], 
The nectin1-binding site remains poorly defined, determined by means of 
insertion-deletion or substitution mutants appears to be more widespread than 
that of HVEM, it seems to be formed by several discontinuos sequences [46-47]. 
Deletion of the first 32 aa of gD abrogate the interaction with HVEM but not 
with nectin1. Critical aa residues for nectin1 binding include V34, Y38 and the 
cluster D215, R222, F223, all of which occupy a same surface of the molecule 
[48-50]. 
Functionally, the endodomain of gD is dispensable: a soluble form of gD, 
deprived of the TM and C-tail regions, is sufficient to complement the 
infectivity of a noninfectious gDnull virus and gD is functional even when 
anchored to the virion envelope through a GPI anchor [51-52]. Hence, the 
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activity of gD reside completely in the ectodomain which may be divided into 
two functional domains, a N-terminal domain  with receptor binding activity that 
takes up the first 250-260 residues and a C-terminal domain with the pro-fusion 
domain (PFD), which lies in 250-310 residues [53]. It is not clear the activity of 
PFD domain but its replacement by heterologous sequences and some 
aminoacids substitutions  impair infection and cell-cell fusion, without affecting 
gD binding property. 
a) 
N- -C 
  
c)b) 
 
Fig. 1.4.A gD Structure a) Domain architetcture of gD b) Ribbon diagram of gD derived from crystal data. c) 
Ribbon diagram of gD HVEM-bound derived from crystal data. 
 
An interesting feature of PFD is its high content of prolines which exibhit 
defined spacings. Substitution of some prolines reduced HSV infectivity 
indicating that they represent  necessary residues. The frequent presence of 
proline rich regions in cassettes that function in protein-protein interaction, 
suggests that the PFD may interact with target proteins. 
Whereas soluble gD is able to mediate the entry of a gDnull virus, the 
interaction with its receptor is not used to anchor the virion to the cell surface 
but probably to trigger conformational changes in gD which lead to the envelope 
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fusion. Structural studies and before biochemical studies done with GST pull 
down experiments had shown that gD may adopt almost two different 
conformations: closed and opened [44 and 54]. In the closed conformation, 
present when gD is not ligated to a receptor, the C-terminal portion of the 
ectodomain folds back on itself and wraps the N-terminal region; in the opened 
conformation,  the binding with a receptor displaced the C-terminus. It is not 
clear how and if  this change from closed to opened conformation triggers fusion 
and if the free terminus of opened gD may act binding other proteins. 
The Ig-like domain in the ectodomain of gD seems to play the role of connecting 
the N-terminal receptor-binding region to the C-terminal region carrying the 
PFD but does not appear to encode executable functions required for viral entry 
into cells at least when the HVEM and nectin1 binding sites are substituted by 
uPA (urokinase plasminogen activator) as noticed in an isolated obtained 
modifying an HSV retargeted to uPA [55]. This isolate had  gD split into two 
polypeptides (A and B), as a consequence of frame shifts and stop codon 
insertions. Polypeptide A was made of uPA fused to gD33-60. Polypeptide B 
started at methionine 219, and thus was gD219-369; it included the α-helix3 plus 
the downstream proline-rich flexible region. It was demonstrated that the uPA 
moiety of polypeptide A could mediate physical interaction with polypeptide B. 
Attempts to generate a split gD in which the polypeptide A lacked the uPA 
moiety and instead consisted entirely of gD sequences (gD1-60) did not yield any 
virus. Possibly the polypeptides A and B are unable to interact one with the 
other in the absence of uPA.  
 
1.4.3.2 gH.gL 
Glycoprotein H,  a 110 kDa glycoprotein encoded by UL22, is essential for 
virion infectivity [56] Neutralizing antibodies to gH block virus entry but permit 
attachment, indicating a role of the protein in a post-attachment step [57]. 
Bioinformatic predictions of structural motifs show that gH ectodomain carries 
elements typical of class I fusion glycoproteins, in particular a highly 
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hydrophobic α-helix (named α-H1) which has features of an internal fusion 
peptide and  two heptad repeats (HR-1 and HR-2) that could interact and adopt a 
coiled-coil conformation, in addition to a less hydrophobic region (named α-
helix2), and a membrane-to-interface hydrophobic sequence [58-61].α-Helix1 
can be functionally exchanged with heterologous fusion peptides (e.g. from HIV 
gp41 and VSV-G), and interacts with lipids of natural and artificial membranes 
[58, 61-62]. Furthermore a mimetic peptide may adopt an α-helical 
conformation. The predicted α-helix is positionally conserved in all examined 
gH orthologs from human and animal herpesviruses, suggesting that it may 
constitute a critical element in the conserved mechanism of herpesvirus fusion.  
Heptad repeats are predicted in all gH orthologs and occupy a canonical position 
typical of class I fusion glycoproteins. A mimetic peptide to heptad repeat-1 can 
adopt an α-helical conformation, and forms a stable complex with the heptad 
repeat-2 mimetic peptide. Peptides mimicking HR-1 or HR-2 block infection 
[59, 60 and 62]. 
The ectodomain of HSV-1 gH also carries a RGD motif (residues 176, 177, and 
178) that is used by  several viruses to attach to integrin molecules and mediate 
the entry into the cells. gH binds integrins [63] but mutation of the RGD to RGE 
seemed not alter the HSV ability to bind and penetrate cells in vitro [64]. 
gH’s function depend on forming a heterodimer complex with gL, whic acts as a 
gH chaperon for its proper processing and trafficking to the viral envelope. The 
non covalent interactions occur between the first 323 amino acids of gH and the 
first 161 amino acids of gL. gL is a soluble glycoprotein of 224 amino acids 
encoded by UL1 gene. It  is unclear that it only enables gH to adopt a correct 
conformation, or plays own specific roles in HSV entry and fusion.  
 
1.4.3.3 gB 
gB encoded by HSV-1 UL27 gene is highly conserved among the Herpesviridae 
family. It is a homotrimeric, 904-aminoacid  type I glycoprotein composed of a 
696-aa ectodomain that is N-glycosilated at multiple sites [65-68, 5], a 69-aa 
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transmembrane domain, and 109-aa carboxy-terminal domain [69-70]. The 
transmembrane domain was proposed to have three segments corresponding to 
residues 727-746, 752-772 and 775-795 which can traverse the membrane three 
times. The third segment was suggested to be the membrane anchoring domain, 
while the first and the second may be peripherally associated with the membrane 
[71]. The cytoplasmatic tail of gB is the longest among HSV-1 glycoprotein and 
has a negative control on fusion. In fact the gB endodomain carries at least two 
functional endocytosis motifs, one di-leucine based (LL871) and one thyrosine 
based (YTQV889-892) [72-74]. They traffic gB from the plasma membrane to 
small endocytic vacuoles which after coalesce, subtracting the amount of gB 
exposed on the plasma membrane and decreasing the ability of the cells to fuse 
with adjacent ones [73, 75]. Besides gB C-tail is the site of syn mutations (syn 
3). Cell infected with syn mutants form syncytia differently from cell infected 
with wild type virus. Syn mutations are thought to affect genes which negatively 
regulate fusion but the mechanism is unknown [76]. 
On the other hand, gB still exerts a positive role in fusion, may be through the 
ectodomain. The requirement of gB in HSV fusion is inferred by numerous lines 
of evidence: HSV-1 mutants lacking gB are not able to enter the cells due to a 
post-attachment defect; gB is necessary in in the cell-cell fusion assay; 
neutralizing antibodies map on gB; mutants temperature-sensitive with affected 
rate entry reside in the gB ectodomain [69-70, 76-84]. The crystal structure of 
part of the ectodomain (from D103 to A730) was recently solved, showing a 
homotrimeric spike made up of five distinct domains in each protomer [84]. 
There isn’t an unique trimerization domain but several contacts between 
protomers, throughout the molecule, contribute to trimer stability. The ten 
cysteines per subunit form only intramolecular bonds. The rod-shaped trimer 
organised around a coiled-coil central core resembles closely to that of VSV G 
in its post-fusion conformation [19]. Domains I and II, the ‘base’ and the 
‘middle’, (similar to domains IV and III of G), adopt a fold similar to pleckstrin 
homology (PH) domains. PH domains are found in cytosolic proteins involved 
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in intracellular signaling, where they mediate both protein-protein and protein-
lipid interactions [85]. gB domain I is structurally homologous to the domain IV 
of VSV G containing two fusion loops at the tip of an elongated four-strand β-
sheet. In gB the two loops lie, the first,  at residues 173 to 179 and the second at 
residues 258-265. Three residue of these loops, W174, Y179 and A261, are 
essential for gB’s function in cell-cell fusion [86].  
  
  
 
Fig. 1.4.C (A) Domain architecture of gB; (B) Ribbon diagram of a single gB protomer; (C) gB trimer; (D) 
Accessible surface area representation of gB trimer [84]. 
 
Domain III (VSV G domain II) is composed by the long α-helix that forms the 
coiled-coil core followed by a short helix and a small β sheet. Domain IV 
(corresponding to domain I of  VSV G), the "crown", doesn’t show homology 
with structures previously described; it is fully exposed on top of the trimeric 
spike. Domain V, the "arm", is a long extension that spans the full length of the 
protomer and makes contact to other two protomers.  
Antibodies with neutralizing activity bind to different regions on the gB surface 
and are against both continuos and discontinuos epitope. Recently functional 
regions (FR) based on neutralizing Mabs had been reclassified holding in 
consideration the solved structure into: FR1  is composed of residues of domain 
I and the C-terminus of domain V; FR2 comprises three overlapping epitopes 
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within domain II; FR3 includes amino acids located between domain III and 
domain IV and FR4 that lie at a unresolved region (Fig 1.4.B) [87]. 
Glycoprotein B together with glycoproteins H and L form the core fusion 
machinery conserved throughout the herpesvirus family. In Varicella-Zoster 
virus (VZV), cytomegalovirus (CMV) and human herpesvirus 8 (HHV-8) the 
action of gB or the gH/gL complex alone could result in fusion, although at a 
very lower level than when all 3 glycoproteins are present [88-90]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.4.B Location of the epitopes of neutralizing MAbs and of FRs on the surface of the crystal structure of gB. 
On the left ribbon diagram of a gB trimer showing in color the epitopes of representative neutralizing MAbs. On 
the right accessible surface area representation of the gB trimer. FR1 to FR3 are indicated with circles. Since 
FR4 is present in an unresolved region of gB, it is symbolically represented with a question mark [87]. 
 
 
HSV-1 gB exhibits 86% identity with HSV-2 gB while shares the 27 % identity 
and 46 % similarity at the protein sequence level with HHV8 gB. 
In the experimental work of this thesis amino acid sequences from HHV8 were 
used so gB HHV8 is dealt with details. 
 
1.4.3.3a gB of human herpes virus 8 
Human herpes virus 8 (HHV8) or Kaposi’s sarcoma associated virus (KSHV) is 
a gammaherpesvirus etiologically linked to the pathogenesis of Kaposi’s 
sarcoma, peripheral effusion lymphoma, and multicentric Castelman’s disease. 
These pathologies occur more frequently in people with severe 
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immunodeficiency. KSHV has been detected in B cells, endothelial cells, 
monocytes and epithelial cells in vivo. In vitro HHV8 can infect a variety of 
human cell types and several animal cells but infection usually evolves as a 
latent infection making difficult to study the virus. Very little is known about the 
entry of HHV8. It has been shown that HHV8 enters in human foreskin 
fibroblast cells (HFF) through clathrin-mediated endocytosis [91] and that 
HHV8 gB, gH and gL (homologues of HSV-1 gB, gH and gL) could mediated 
the fusion of CHO cells with embryonic kidney cells and B lymphocytes [90]. 
HHV8 is able to bind to heparan sulfate, thus infectivity is reduced by enzymatic 
removal of cell heparan sulfate, virus binding is blocked or displaced by soluble 
heparin and binding is drastically reduced on CHO cells that are deficient in HS 
[92]. Probably like HSV-1, the attachment allowes to concentrate the virus on 
the cell surface and is followed by the binding to one or more cell receptor 
molecules. Several lines of evidence indicate that attachment is mediated by two 
glycoproteins gpK8.1A and HHV8 gB. HHV8 gB is a type I membrane 
glycoprotein 845 amino acids in lenght, with a cleavable signal sequence of 23 
residues, a predicted transmembrane domain between residues 710-729 and 13 
putative N-glycosylation sites. There is a potential proteolytic cleavage site 
(RKRR/S) at amino acid position 440-441, and cleavage at this site would result 
in two proteins with predicted masses of about 48 and 45 kDa [93, 94]. The 
cellular distribution and processing of gB depend on the cell type in which the 
protein is expressed; it is not cleaved when expressed transiently in CHO and 
COS-1 cells while in BCBL-1 cells is synthesized as a 112 kDa precursor 
protein, undergoes cleavage and processing, and the envelope-associated form 
consist of 75 and 59 kDa polypeptides that form disulfide-linked heterodimers 
and multimers [92, 94]. 
HHV8 gB may also bind cell integrins thanks to an integrin-binding RGD motif 
that lies near the signal sequence. Soluble gB induces the integrin-mediated 
activation of FAK (focal adhesion kinase) [95]. KSHV infectivity but not 
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binding of fibroblast and endothelial cells is neutralized by RGD peptides and 
by antibodies to α3 and β1 integrins. 
A recent study showed that KHSV utilizes the dendritic cell-specific ICAM-3 
grabbing nonintegrin (DC-SIGN; CD209) as a receptor for infection of myeloid 
DCs and macrophages [96]. It is a type II C-type lectin that is expressed on 
myeloid DCs, IL-4-treated monocyte-derived DCs, macrophages and IL-13-
activated monocyte-derived macrophages. DC-SIGN and other C-type lectins act 
as pathogen recognition receptors that alert macrophages and DCs to take up and 
process pathogens for Ag presentation to T cells. Certain viruses, parasites, 
yeast, and bacteria can subvert this immune function by using DC-SIGN as a 
receptor.  
Another receptor used by KSHV is the 12-transmembrane transporter protein 
xCT for entry into adherent cell  but doesn’t seem involved in infection of B 
cells which are important target for KSHV infection [97]. 
 
1.5 HSV EGRESS 
 
The assembly of herpesviruses begins in the nucleus of an infected cell, where 
newly synthetized genomes are packaged into preformed capsids. In a second 
time nucleocapsids contact the inner nuclear membrane and bud into the 
perinuclear space. In this process HSV UL31 and UL34 proteins interact with 
the nuclear envelope and recruit cellular protein kinase that partially dissolve the 
nuclear lamina providing the sites for envelopment. The subsequent steps of 
egress have been extensively debated. An earlier model, reffered as the single 
envelopment model, suggested that perinuclear enveloped virions are 
transported to the cell surface via the secretory pathway and the envelope 
glycoproteins are processed in situ [98]. In this pathway the virion manteins the 
tegument acquired in the nucleus as well as the envelope acquired at the inner 
nuclear membrane. More recently it was proposed that capsids pass across the 
nuclear envelope through enlarged nuclear pores into the cytoplasm and undergo 
their first envelopment at TGN [99]. Critics raised against this models are that it 
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is based solely on electron microscopic observations and that other groups have 
not seen dilated pores at the late stages of infection or the exit of capsids through 
nuclear pores. However the current widely accepted model, supported by 
biochemical and morphologic evidence, is the de-envelopment re-envelopment 
egress. In this model virions fuse their primary envelope with the outer nuclear 
membrane such that unveloped nucleocapsids are released into the cytoplasm 
where capsid-proximal tegument proteins assemble at the capsid. After that they 
acquire other tegument proteins and a second envelope with mature 
glycoproteins by budding into the trans-Golgi network (TGN) or into a 
endosomal compartement [100] (Fig 1.5.A). It isn’t clear how the de-enveloped 
nucleocapsid can travel through the cytoplasm to TGN. An other question is 
why it was found that perinuclear virions carry immature oligosaccharides, 
intracytoplasmatic virions carry both intermediate and mature type of 
oligosaccharide and extracellular virions carry only mature oligosaccharides if 
the secondary envelope is taken at TGN. If the secondary envelopment occour at 
the cis- or medial-Golgi is difficult to understand how the virions travel from 
these to farther compartments of the exocytic pathway to obtain their final 
envelope. 
It is also unclear how primary envelope fuses with the outer nuclear membrane. 
HSV mutants lacking any one of the four glycoprotein essential for entry, are 
not substantially compromised in virus egress yet cannot enter cells. Otherwise 
recently an HSV mutant lacking both gB and gH was shown to accumulate as 
enveloped virions in the perinuclear space and in the nucleoplasm. While viruses 
lacking just one of the two proteins do not exhibit substantial defects in nuclear 
egress suggesting that they are required also for fusion at the outer nuclear 
membrane and act in a redundant manner [101].  
Other viral proteins, notably gK and UL20, seem to be involved in subsequent 
steps after primary envelopment, thus in their absence virus particles accumulate 
in the perinuclear space or cytoplasm. These proteins, however, appear to inhibit 
fusion performed by the quartet [73]. 
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Fig. 1.5A Alternative pathways of HSV egress from infected cells. The single envelopment pathways is 
depicted to the left, and the double envelopment to the right. Perinuclear virions and nuclear membranes are 
decorated with glycoproteins of different color than virions at level of the Golgi apparatus and TGN, as well as 
extracellular virions, to emphasize that the oligosaccharide moieties of the viral glycoproteins are of the 
immature type in early exocytic compartment, but are of the mature type in the late exocytic compartments and 
in extracellular virions. The drawingconsiders also the possibility that nucleocapsids exit the nucleoplasm 
through modified nuclear pores, without transiting across the perinuclear lumen. 
 
In the final envelopment seems to have a role the glycoproteins gE, gI and gD. 
In PrV the simultaneous deletion of gE-gI and gM drastically inhibits plaques 
formation and replication and induces intracytoplasmatic aggregation of capsids 
surrounded by tegument proteins. In HSV similar defects are obtained with 
deletions of gD and gE or gD, gE and gI. It was proposed that gD and the gE-gI 
act in a redundant fashion [102]. Also several viral tegument proteins are 
thought to play critical roles in cytoplasmic envelopment. These include 
homologues of the HSV-1 UL11 and UL36 genes [103-106] the 
alphaherpesvirus UL48 and UL51 genes [107-110] and the CMV UL32 gene 
[111]. It has to be explored the requirement of cellular proteins, recently it has 
been shown that HSV-1 cytoplasmatic envelopment requires functional Vps4 
that is a cellular enzyme essential for multivescicular endosome (MVE) 
biogenesis [112]. Otherwise whichever egress model is correct, the identity of 
the membranes that serve as platforms for secondary envelopement is still 
unclear as well as if the enveloped virus reach the extracellular space directly by 
budding across the plasma membrane or by budding into the lumen of cellular 
nucleus
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organelles, with luminal virions released into the extracellular enviroment via an 
exocytic mechanism or both. Many enveloped virus i.e. HIV seems to use for 
this process the cellular MVE budding machinery. 
 
1.6 INTRACELLULAR TRAFFICKING AND THE 
MULTIVESCICULAR BODIES LATE ENDOSOME 
 
In eukariotic cells cell, surface lipids, proteins, ligands and other solutes can be 
internalized by endocytosis and undergo opposite fates, some being routed 
towards lysosomes for degradation and others being retrieved for reutilization. 
In the sorting of endocytosed molecules a key role is held by multivescicular 
bodies [reviewed in 113-116]. 
The multivescicular body (MVB) was described by electron microscopists as an 
organelle that consist of a limitating membrane enclosing many (sometimes 
several hundred) internal vescicles of 40-90 nm. Later was shown that it 
represent an intermediates of the endocytic pathway and sometimes on refers to 
it as multivescicular endosome MVE. MVBs are formed by invagination and 
budding of vescicles from the limiting membrane of sorting (early) endosomes 
into the lumen of the compartment. During this process, proteins destined for 
degradation are sorted into the forming intralumenal vescicles (ILVs). Mature 
MVBs fuse with the lysosomes and deliver the ILVs to the lysosomial lumen 
where the vescicles and cargo are degradated. Transmembrane proteins may also 
are retained on the limiting membrane of MVBs and are either recycled to the 
trans-Golgi network and plasma membrane or are delivered to the limiting 
membrane of lysosomes. MVBs not only contain molecules endocytosed but 
also receive biosynthetic cargo from TGN including precursor of lysosomial 
enzymes. In specialised cell types, MVEs serves as intermediates in the 
formation of secretory lysosomes that fusing with the plasma membrane 
released the intraluminal vescicles (Fig. 1.6.A) [114]. 
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Fig. 1.6A Formation and functions of MVEs. Multivesicular endosomes are formed after invagination of the 
limiting membrane of the sorting endosome. They can serve different functions in different cell types, such as 
being precursors for (a) lytic granules in T lymphocytes, (b) MHC class II compartments and exosomes in 
antigen-presenting cells, (c) melanosomes in melanocytes, and (d) late MVEs/lysosomes in most nucleated cells. 
Both endocytic and biosynthetic proteins are sorted in and out of MVEs, indicated by arrows. Clathrin-coated 
buds are found at the plasma membrane, the TGN and on tubular regions of the sorting endosome, whereas flat 
clathrin coats are found on early endosomal compartments. Clathrin is indicated in red. 
 
1.6.1 The role of ubiquitination in sorting 
Ubiquitination causes sorting toward lysosomes from a number of 
compartments, including the Golgi (where ubiquitin serves as a signal to divert 
proteins to endosomes), the cell surface (where promotes internalization), and 
the MBV (where mediates incorporation into ILVs). The transfer of ubiquitin 
(Ub) to substrate proteins involves the sequential action of three classes of 
enzymes: an activating enzyme E1, a conjungation enzyme E2, and a ligase E3 
[117]. Ub is typically attached to lysine side chains of substrate proteins and 
forms an isopeptide bond, but can also be covalently linked to other Ub moieties 
on target proteins to form polyubiquitin chains. E3 can interact directly with its 
substrate or uses other adaptor proteins to target its substrates. The majority of 
Ub is removed from proteins, by Ub-specific proteases or deubiquitinating 
enzymes (DUbs), just prior to the delivery of cargo into ILVs. Although certain 
Ub-dependent functions involve the formation of long polyubiquitin chains, 
MVB targeting does not; the fusion of a single Ub is sufficient to direct ILV 
targeting, and there are few long polyubiquitin chains on MVB cargo proteins 
[118-119]. Generally polyubiquitinated proteins are targeted to proteasomes but 
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polyUb might also function as an MVB targeting signal i.e. the yeast Gap1 
becomes polyubiquitinated in the TGN and this signal its entry into MVBs 
[120]. Besides some proteins like yeast Sna3 or mammalian LRP don’t require 
ubiquitination for sorting into ILVs [121-122]. Ub is recognized by an 
expanding group of endosomal proteins, which may act as Ub-sorting receptor 
responsible for binding and directing cargo. 
 
1.6.2 MVBs biogenesis 
The formation of lumenal membranes so the MVBs biogenesis depends on the 
function of a group of at least 18 conserved proteins originally described in 
yeast as class E Vps (Vacuolar Protein Sorting) proteins [115]. Loss of class E 
protein function rapidly leads to the accumulation of endosomal cargo in a 
anormally enlarged, higly tubulated endosome membrane compartment that fails 
to mature normally into MVBs, called the ‘class E compartment’. For each 
known component of the yeast MBV sorting machinery, one or more 
mammalian homologues have been identified suggesting a higher complexity 
(Tab.1.6.A). Furthermore in mammalian cells the depletion of individual E Vps 
proteins causes varying phenotypes probably because they have more 
intermolecular connections than in yeast and that may compensate for the loss of 
a single component. The majority of the class E Vps proteins are constituents of 
three separate heteromeric protein complexes called ESCRT-I, ESCRT-II and 
ESCRT-III (Endosomal Sorting Complex Required for Transport). These 
protein complexes are transiently recruited from the cytoplasm to the endosomal 
membrane where they function sequentially in the sorting of transmembrane 
proteins into the MVB pathway and in the formation of MVB vesicles. 
Initially, the ESCRT-I protein complex, recruited from the cytoplasm by Vps27, 
binds to ubiquitinated endosomal cargo and in some way activates ESCRT-II. 
ESCRT-II in turn initiates the oligomerization of at least four small coiled-coil 
proteins (Vps2, Vps24, Vps20, Sfn7), resulting in the formation of a large 
endosome-associated structure, like a lattice, the ESCRT-III complex. ESCRT-
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III concentrates the MVB cargo and recruits additional factors such as Bro1 and 
Vps4. 
 
Yeast gene     Mammalian gene      Motifs                 Binds to            Modification     Complex    
Vps23/Stp22 TSG101 UEV, Coiled-coil Ubiquitin Ubiquitinated  
Vps28 VPS28    ESCRT-I 
Vps37 VPS37A-D Coiled-coil    
Vps22 EAP30 Coiled-coil    
Vps25 EAP25    ESCRT-II 
Vps36 EAP45 NZF Ubiquitin   
Vps2/Did4 CHMP2A, B Coiled-coil    
Vps20 CHMP6 Coiled-coil  Myristoylated ESCRT-III 
Vps24 CHMP3 Coiled-coil    
Sfn7/Vps32 CHMP4A-C Coiled-coil    
Vps27 HRS UIM, FYVE,VHS Ubiquitin, PI3P Ubiquitinated Vps27/HRS 
Hse1 STAM1, 2 UIM, VHS, SH3 Ubiquitin Ubiquitinated  
Vps4 VPS4A, B AAA, Coiled-coil   Vps4 
Bro1/Vps31 A1P1/ALIX Coiled-coil LBPA  not known 
Vps60/Mos10 CHMP5 Coiled-coil   not known 
Fti1/Did2 CHMP1A, B Coiled-coil   not known 
Vta1 SBP1    not known 
Tab. 1.6.A. Class E Vps proteins (modified from ref. 115) 
 
Bro1 recruits the deubiquitinating enzyme Doa4, which removes the ubiquitin 
tag from the cargo protein prior to sorting into the MVB vesicles. In mammalian 
cells, the homologues of the yeast Bro1, called AIP1 (ALG2-interacting protein 
1) or Alix (ALG2-interacting protein X), appears to serve as a bridge between 
ESCRT-I and ESCRT-III complexes and also to regulate the interaction of ILVs 
with the limiting membrane of lysobisphosphatidic acid (LBPA)-containing 
endosomal membranes. 
Vps4 is a multimeric AAAtypeATPase, that after protein sorting has been 
completed, binds to ESCRT-III and disassembles the complex in an ATP-
dependent manner. The dissociation of the ESCRT machinery is a prerequisite 
for vesicle formation. 
The ubiquitination seems to have not only a function in sorting of cargo but also 
in MVB formation. The impairing of ubiquitin binding of the yeast ESCRT-II 
subunit Vps36 and of the yeast ESCRT-I subunit Vps23 affects MVBs 
formation. One possible explanation is that the interaction of ESCRTs 
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complexes with ubiquitinated cargo notonly serves to sort cargo but also has a 
regulatory function 
in activating downstream events, such as the formation of ESCRT-III. Another 
possibility is that ESCRTs complexes, might interact not only with ubiquitinated 
cargo but also with ubiquitinated proteins of the MVB sorting machinery itself, 
promoting the formation of a functional sorting complex. However, a study on 
TSG101 (mammalian Vps23 homologue) has shown that its ubiquitination 
results in decreased MVB sorting and in its solubilization from the endosomal 
membrane, suggesting that in case of ESCRT-I at least, ubiquitination plays a 
negative regulatory role. Also Vps27 (mammalian HRS), that recruits ESCRT-I 
from the cytoplasm to endosome, has a Ub binding activity, but in this case 
mutations only affect sorting of ubiquitinated cargo but not the formation of 
MVBs. 
The formation of MVB vesicles is unique in that it is directed toward the lumen 
of the compartment, rather than the cytosol. It is not easy to imagine how the 
ESCRT proteins could be directly involved in the invagination of the endosomal 
membrane 
without getting trapped in the lumen of the forming vesicle and which role have 
lipids in this process. Differential lipid sorting render ILVs susceptible to 
degradation and the limiting membrane resistant to hydrolase, but the lipid 
composition and localized lipid remodeling  may also control the organization of 
the protein sorting machinery and perhaps the budding. Consistent with this, 
phosphatidylinositol 3-phosphate (PI3P) recruits Hrs to endosome, antibodies 
against lyso-bisphosphatidic acid (LBPA) inhibit MVBs formation and 
sphingomyelin and cholesterol are candidates for mediating protein sorting to 
MVBs. 
 
1.6.3 Viruses and MVBs 
The production of various enveloped RNA viruses such as HIV depends on 
some of the same protein machinery that controls MVB formation (Fig.1.6.B). 
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Topologically, the budding of viruses out of the cytosol (either from tha cell 
surface or from endosome) is similar to the budding of endosomes from the 
limiting membrane to form ILVs.  
Gag, the major structural protein of retroviruses, can assemble and bud from 
cells in the absence of any other viral factor [123]. Mutational analyses of Gag 
have defined short sequences motifs required for efficient particle release termed 
late or L domains to reflect their function late in the virus budding process [124-
125].  
Three classes of motifs have been defined in viral L domains: P(T/S)AP, PPXY 
(where X usually is a proline), and YP(X)nL. Late domain have been identified 
in retroviruses, rhabdoviruses, filoviruses, arenaviruses and probably also in 
ortho- and paramyxoviruses. It’s now clear that different L domains bind 
different cellular factors and in particular proteins of the MVBs biogenesis 
machinery. PTAP late domains function by recruiting TSG101, YP(X)nL 
domain seems to facilitate virus budding by binding AIP1/Alix, PPXY  motifs 
interact with proteins containing WW domains (two Trp separated by about 40 
amino acids) like Nedd4 family of ubiquitin E3 ligases.  Mutations in TSG101 
and AIP1 affect the release of retroviruses which have PTAP and YP(X)nL late 
domains.  
Mutants on VPS4A and B proteins are also potent inhibitors of retrovirus 
budding and block the release of retroviruses that leave the cell via all three 
known late domains, suggesting that retroviruses all enter the MVB pathway 
upstream VPS4, regardless of which class E proteins they bind. 
Ubiquitin transfer also plays importants roles in the budding of virus that utilize 
P(S/T)AP and PPXY late domains. Mutations in Ub can inhibit the release and it 
is known that several retrovirus incorporate high level of Ub into their particles. 
Gag proteins are monoubiquitinated at multiple sites and the levels of 
ubiquitination are altered by the presences or not of L domains. Althought 
ubiquitin transfer is clearly important for retrovirus release, it has not been 
established that Gag proteins are the functional targets for ubiquitination, indeed 
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it has been reported that amino acid substitutions which prevent Gag from being 
ubiquitinated do not impair virus budding [126]. 
 
  
 
 
Fig. 1.6.B (from ref. 125) Model for retrovirus release. On the left, schematic representation of endocytosis 
and MVB sorting of an activated growth factor receptor. An Hrscontaining complex (dark purple) recognizes 
and sequesters ubiquitylated cargo (Ub, light purple) at clathrin-rich regions of the early endosomal membrane. 
Hrs recruits ESCRT-I (I, red) through a direct interaction with Tsg101. ESCRT-I in turn recruits additional 
components of the MVB pathway, i.e., ESCRT-II (II, green) and ESCRT-III (III, blue), to assemble into a 
functional sorting complex. AIP1/Alix (brown) is recruited to the assembled complex and in mammaliancells 
bridges ESCRT-I and -III. The AAA ATPase Vps4 (red) is critical for disassembly of the complex following 
inward budding of vesicles into the endosomal lumen. On the right is depicted the hijacking of MVB sorting 
machinery for virus release. HIV-1 Gag is believed to mimic Hrs in triggering membrane recruitment of ESCRT-
I. Virus particles are shown to assemble and bud at the plasma or to be released (e.g., from macrophages) 
through the exosome pathway following assembly in the MVB. 
 
The MVB machinery is not only hijacked by viruses to egress from cell, but 
some viruses like VSV use it to entry. VSV envelope fuse with the membrane of 
ILVs leading the release of the nucleocapsid into the lumen of these vescicles to 
be safely transported across the cytoplasm then back-fusion events allow its 
final release with a mechanism that require LBPA and AIP1 [127]. 
Several lines of evidence indicate that MVB biogenesis machinery has a role in 
HSV envelopment.Vps24 and Vps4 are critical for efficient HSV-1 
assembly/release, very likely for HSV envelopment [112 and 128]. The MVB 
compartment was morphologically altered in HSV-infected cells, and appeared 
to be enlarged compared to that of uninfected cells. gB accumulates at MVB 
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membranes and its intracellular trafficking requires a correct MVB biogenesis 
process. gB is ubiquitinated in infected cells and in its ubiquitination seems to be 
involved in part K63, a residue implicated in endocytosis and not in proteasome-
dependent degradation [128]. A gB mutant lacking the 37 most C-terminal 
amino acids of the cytoplasmic tail (gB∆867) and impaired in its ability to 
accumulate at cytoplasmic vesicles [73], is significantly less ubiquitinated than 
the wt protein [128]. Virions carrying in their envelope gB∆867 are impaired most 
likely in cytoplasmic envelopments and egress [128]. The site of gB 
accumulation as well as its ubiquitination makes it likely that the membranes of 
the MVBs serve as platforms for HSV envelopment, at least in some cells. 
Alternatively, the site of envelopment may be membranes other than those of the 
MVBs, to which components involved in MVB biogenesis are recruited through 
the intervention of gB and possibly additional viral proteins; candidates are the 
tegument proteins, predicted to contain L-domain motifs [112 and 128]. 
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2. OBJECTIVES AND EXPERIMENTAL DESIGN 
 
 
2.1 DETECTION OF HSV-1 GLYCOPROTEINS INTERACTIONS 
 
The entry of herpes simplex virus (HSV) into cells takes place in 3 steps. In the 
first, two viral glycoproteins, gC and gB bind to heparan sulphate proteoglycans. 
In the second step, another glycoprotein, gD, interacts with at least one of three 
alternative receptors: nectin 1, herpesvirus entry mediator (HVEM) or modified 
heparan sulfate. In the third step, gH, gL and gB execute the fusion of viral 
envelope with the cell membranes, either plasma or endosomal.  
A key question in HSV entry/fusion centres on how gD signals the encounter 
with one of its receptor to the others virion glycoproteins required to execute 
fusion. 
The gD ectodomain is organized in two distinct regions, a N-terminus (aa 1-260) 
carrying the receptor binding sites, and the C-terminus (aa 260-310) carrying the 
profusion domain required to trigger fusion but not for receptor binding. In the 
unliganded state, the virion gD adopts a conformation in which the flexible C-
terminus of the ectodomain folds back, wraps the N-terminus and masks 
receptor-binding sites. At receptor binding, the C-terminus is displaced leading 
gD to adopt an open conformation. This conformational change and/or the 
exposed residues trigger the fusion process in some ways [129]. Our working 
model envisions that, after receptor binding, gD forms complexes with 
downstream glycoproteins, or a subset of them. 
The fusion between cells induced by co-expression of the all four fusogenic 
glycoproteins might be an useful surrogate of viral envelope-cell membrane 
fusion. 
A method that allows to detect protein interactions in living cells is the 
bimolecular complementation assay. This method is based on observation that 
many reporter proteins, including green fluorescent protein (GFP), β-Lactamase, 
dihydrofolate reductase, firefly and Renilla lucferase, can be divided into 
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fragments that neither of them retains significant activity by themselves but can 
refold in a functional complex when they are brought into sufficient closeness. 
Therefore is possible restores and detects the fluorescence emission of a split 
GFP protein if its two halves are fused to two proteins that are destined to 
interact each other and only when they do it [130] . The objective of this study 
was to investigate, in intact cells, the interactions that occur among the quartet 
of membrane glycoproteins required for HSV entry into the cells 
To this aim: 
- we searched evidence that the bimolecular complementation assay was 
suitable to the detection of membrane-bound protein interactions fusing 
two fragments of the enhanced green fluorescence protein EGFP to two 
known interacting partners, gD and its receptor nectin 1. 
- We fused the N- and the C- portions of EGFP to the endodomains of HSV 
glycoproteins to investigate their supposed interactions. 
 
 
2.2 CHARACTRIZATION OF MUTANTS IN THE gD PRO-FUSION 
DOMAIN 
 
The molecular events that follow receptor recognition by gD and precede the 
execution of fusion, referred to as triggering of fusion, are poorly understood. 
The gD ectodomain seems to encode two functions: the receptor binding and a 
signaling activity of receptor binding to downstream glycoproteins. The second 
activity may be carried by the region from aminoacid 260 to 310, which is 
required for viral infectivity and fusion but not for receptor binding. This region 
was called pro-fusion domain (PFD). The pro-fusion domain has an high content 
of prolines which exhibit somewhat regular spacings, feature often present in 
protein-protein interacting domains. 
The substitution of some prolines reduced HSV-1 infectivity in a 
complementation assay, indicating that prolines represent critical residues. 
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The objective of this study was to define the regions/sequences involved in the 
pro-fusion activity of gD more accuratly. 
To this aim: 
- we mapped subregions of the pro-fusion domain testing the activity of 
mutants in which half domain was substituited by sequences from CD8; 
- we mutated proline-glutamic acid doublets in the N-terminal portion of 
PFD to investigate their activity. 
 
2.3 CONSTRUCTION OF gB CHIMERAS TO IDENTIFY FUNCTIONAL 
DOMAINS. 
 
To enter the cell HSV-1 requires the quartet made of glycoproteins D, B, H and 
L. The roles of each component of the quartet are poorly understood. Available 
evidence indicates that, in the receptor-bound conformation, gD recruits, or 
activates the fusion executors gB and or gH/gL heterodimer. Of the three 
executors, gH appears to contain elements associated with fusion proteins, e.i. a 
hydrophobic α-helix that exhibits the properties typical of a fusion peptide and 
two heptad repeats, capable to form coiled coils and to interact with each other. 
On the other hand gB has features typical of viral fusion protein as showed from 
the crystal structure recently solved. gB structure is similar to that of the 
postfusion form of vescicular stomatitis virus (VSV) glycoprotein G, the sole 
responsible for VSV entry. Thus, comparison between G and gB domains does 
not explain how gB functions in concert with the other three glycoproteins of the 
HSV-1 fusion machinery. Furthermore VSV-G needs low pH for its trigger, 
while gB is required for fusion even when HSV-1 enters into cell in a pH 
independent way. 
The current model of HSV entry envisions that the four glicoproteins interact 
with each other before or during fusion, the details of the interactions are not 
understood. The ectodomain of gB is known to be involved in entry. 
Temperature sensitive virus and a mutation that alters the rate of entry map to 
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gB ectodomain. Furthermore, gB ectodomain harbors the epitopes of several 
neutralizing antibodies.  
gB has homologs in all herpesviridae family and in particular the position of ten 
cysteines in the ectodomain is highly conserved. In the past linker-insertion 
mutagenesis has been applied to gB to identify functional domains; however 
insertions exerted a detrimental effect on its folding [77, 83]. It is likely that 
point mutations would be less disruptive to protein structure, but the size of gB 
makes it impratictical to identify functional domains by this approach. When 
this work started the crystal structure was not solved and the only information 
available was that the conservation of the cysteines position was critical. 
 
The objective of this study was to define the sequences involved in the fusion 
activity of gB and, in particular, the domains involved in the interaction with 
gD, gH and gL. 
To this aim: 
- we inserted the 5E1 epitope in the poly-lysine region of gB; we truncated 
the c-ter tail that carries the endocytoses motifs to enable cellular 
accumulation of the protein. 
- we inserted restriction sites adjacent to two consecutive cysteines of gB to 
substitute, the sequences embedded, with homologous sequences derived 
from the HHV8-gB. 
- we tested the chimeras obtained for their activity in cell-cell fusion assay, 
in the complementation of a gB -/+ virus and in a pull-down assay from 
gH or gD fuse to the Strep-Tactin affinity tag. 
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3. MATERIALS AND METHODS 
 
3.1 CELLS AND VIRUSES  
 
Baby hamster kidney (BHK) cells, 293T and COS cells were grown in 
Dulbecco’s modified Eagle medium (DMEM) supplemented with 5% fetal 
bovine serum (FBS). The receptor-negative J, J-nectin 1, and J-HVEM cells 
were described in refs. 33 and 53.  
HSV-1(F) is described in ref. [131]. In gD-minus F-gDβ virus, the gD gene was 
replaced with Lac-Z gene [132]. The virus was grown in R6 cells to obtain (gD-/+ 
stock). R6 cells express HSV-1 gD under control of UL26.5 promoter [11]. 
∆gB-K∆T mutant was grown and titrated in gB-expressing D6 cells to produce 
complemented gB–/+ stock. 
 
3.2 PLASMID CONSTRUCTION 
 
3.2.1. Generation of plasmids for spilt-EGFP complementation assay 
The mammalian expression plasmids for gH in the MTS vector, and gD and 
nectin1 in pcDNA3.1 [33 and 47] were site-directed mutagenized 0 to 10 aa 
upstream of the stop codon, in order to generate restriction sites for the 
insertion of N or C amplimers. The sites were SphI for gH and BglII for gD or 
nectin1. Where necessary, the BglII site of pcDNA3.1 was preliminarily 
eliminated by digestion, filling in by T4-DNA polymerase and religation. N 
and C sequences were PCR amplified from pCMS-EGFP (Clontech) with the 
primer pairs (or variations thereof) 5'CCCAGATCTCCATGGTGAGCAAGGGCG 
AGGAGCTGT plus 5'GGGAAGCTTCTACTTGTCGGCCATGATATAGACGTTG or 
5'CCCGCTAGCTCAGAAGAACGGCATCAAGGTGAACT plus 5'GGGAGATCTTAC 
TTGTACAGCTCGTCCATG CCGAGA, respectively. 
N amplimer was ligated with BglII-HindIII-digested gD plasmid or SphI-
BglII-digested gH plasmid, generating gDN and gHN. The C-EGFP amplimer 
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was ligated with digested nectin1 (BglII-XhoI) and gH (SphI-BglII) plasmids, 
generating NectC and gHC. The gC gene sequence was PCR amplified from 
DNA of HSV type 1 (F) with primers 5'AGATCTAGGCCTATGGCCCCGGGGC 
GGGTGGGCCTTGCCGTGGTCCTGTGGAGCCTG and 5'GAAGATGCGGCCGCTTA 
GCTAGCCGCCGATGACGCTGCCGCGACTGTGATGTGCG. The StuI-NheI-
digested gC amplimer and the NheI-BglII-digested C amplimer were ligated 
with StuI-BglII-digested MTS vector. The gB-encoding plasmid in pcDNA3.1 
was deleted of the endodomain sequences that carry endocytosis motifs, from 
aa 867 to the stop codon (gB 867), in order to maximize gB expression [73]. 
The gBC chimera was generated by mixing gB 867 and C amplimers, 
generated with primer pairs 5'GGCTGGATCCTCCCCGTAGTCCCGCCATGC3’  
plus 5’CCTTGATGCCGTTCTTCTGAGATCTCTTCTTCTTGGCCTTGTGTTC3’ and  
5'GAACACAAGGCCAAGAAGAAGAGATCTCAGAAGAACGGCATCAAGG plus 
5'GGGAAGCTTTTACTTGTACAGCTCGTCCATGCCGAGA3’, followed by 
ligation with BamHI-HindIII-digested pcDNA3.1. 
 
3.2.2 Generation of plasmids used to define functional subdomains in gD-
PFD 
First, we derived gD-PFD/2; the gD1-260CD8 construct was amplified up to 
amino acid 285 with primers 5′-CCCTCTAGACTCGAGCGTTCCGGTATGGGGG-
3′ and 5′-CAAGTTTGGTGGGATTTGCGGCGCCACCTGCGACGCGATGGTGGGCG 
CCGGTGT-3′. Amplimer 2, derived by amplification of the gD gene with 
primers      5′-CTCTTGGAGGACCCCGTGGGGACGCCCCTGTCCCTGCGCCCAGA 
GGCG-3′ and 5′-GCGGTTTAAACTGAATTCTCTAGTAAAACAGGGG-3′, 
contained the gD amino acid 285-stop codon. Each amplimer contained 
overlapping sequences (contained in the primers) with the other amplimer. 
The amplimers were mixed and further amplified with the external primers. 
The product was cloned into pcDNA3.1(-) at the XhoI and EcoRI sites. To 
generate gD∆PFD and gD-PFD/1, we inserted an Asp718 site at amino acid 310 
of gD1-260CD8. Digestion with Asp718 and EcoRI removed the 
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transmembrane (TM) and cytoplasmic tail (C-tail) of CD8, which were 
replaced with the TM and C-tail gD sequences, and amplified with primers   
5′-CATCCCCCGGGTACCCCGAACAACATGG-3′ and 5′-GCGGTTTAAACTGAAT 
TCTCTAGTAAAACAGGGG-3′, thus generating gD∆PFD. To generate gD-PFD/1, 
the latter construct was PCR-amplified from amino acid 285 to the stop codon 
with primers 5′-GGTCTCTTTTGTCTCGAGCGTTCCGGTATGGGGG-3′ and         
5′-CGCCTCTGGGCGCAGGGACAGGGGCGTCCCCACGGGGTCCTCCAAGAG-3′. 
A second amplification product, containing gD amino acids 1-285 plus the 
natural gD signal sequence (amino acids -25 to -1), was derived with primers 
5′-CTCTTGGAGGACCCCGTGGGGACGCCCCTGTCCCTGCGCCCAGAGGCG-3′ 
and 5′-GCGGTTTAAACTGAATTCTCTAGTAAAACAGGGG-3′. The two 
amplimers contained overlapping sequences and were mixed and amplified 
with external primers. The final product was cloned in pcDNA3.1(-) at the 
XhoI and EcoRI sites.  
gD mutants E259A-P261L (1), PE266-267LA (2), PE270-271LA (3), and 
PED273-274-275LAA (4) were obtained by site-directed mutagenesis of wt-
gD-encoding plasmid described in ref. 33. Mutagenesis was performed with 
the following primers: (1) 5′-GCTGCCCCCGGAGCTCTCCGCGACCCTCAACG 
CCACGCAG; (2) 5′-CCCAACGCCACGCAGCTAGCACTCGCCCCGGAAGC;       
(3) 5′-GCAGCCAGAACTCGCGCTAGCAGCCCCCGAGGATTC; and (4)  5′-CTC 
GCCCCGG AAGCGCTAGCGGCTTCGGCCC TCTTGGAG. 
 
3.2.3 Generation of plasmids encoding gB chimeras 
a) gB5E1N
To generate gB5E1N, two restriction sites, BamHI and EcoRI, were inserted 
at residues 68 and 77, respectively, by site-directed mutagenesis of 
plasmid for gB in pcDNA3.1. Mutagenesis was performed with the 
following primers: BamHI, 5’CCAACGGGGGACACGGATCCGAAGAAGAA 
CAAA; EcoRI, 5’GAACAAAAAACCGAATTCCCCACCGCCGCCGCGCCC. An 
amplimer of 5E1 epitope [133] was generated by extension of two 
synthetic partially overlapping oligonucleotides: 5’CTATTCGGAT 
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CCGAGTCGACCAGGAAGCACTACACCCTCTGGGAACTCTGCAAGATATGGG 
plus AGTAATGAATTCGGAGTTATACTTCTAGGTGTGTTATTCCCATATCTT 
GCAGAGTTCCCAG. The amplimer was cleaved with BamHI and EcoRI, 
and ligated in predigested gB. 
b) gB5E1N∆867 
To remove the endocytosis motifs located in the cytoplasmic tail, 
downstream of aa 867 of gB, a stop codon was inserted at the 
corresponding aa of gB5E1 by site-directed mutagenesis performed with 
primer described in ref. 73. The resulting construct was named gB5E1N∆867. 
c) gBC3C4 
XbaI and HpaI restriction sites were inserted at aa 217 and aa 270 (we 
always refer to amino acid position in wt-gB) respectively, by site-directed 
mutagenesis of gB5E1N∆867 with the following primers: 5’GTACGTGCGCAA 
CAATCTAGAGACCACCGCGTT and 5’ GTACGGGACGACGGTTAACTGCATC 
GTCG. Both mutations were silent. The restriction sites inserted were 
adjacent to the third and the fourth cysteines of gB ectodomain after 
cleavage of the signal sequence thus the construct obtained was named 
gBC3C4. This kind of nomenclature was used for all mutants. 
d) gBC1C3C4 
A HindIII restriction site was inserted by site-directed mutagenesis in 
gBC3C4 generating the substitution N112S. The primer used was the 
following: 5’GAACACCGATGCAAGCTTTTACGTGTGCCC. The construct 
was named C1C3C4.  
e) gBC6 
To generate gBC6, a XhoI site was introduced by site-directed 
mutagenesis in gB5E1N∆867 by means of the oligonucleotide 5’ CCTGGGGGA 
CTGCCTCGAGAAGGACGCCCGCGA.  The mutagenesis inserted the 
following substitutions: I412L and G413E. 
f) gBC5VC6 
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A XbaI restriction site was inserted by site-directed mutagenesis in gBC6 
with primer 5’GCCCGTCGGTCTGCTCTAGAACCAAGTGGCAGG generating 
the substitution T365S and M366R. 
g) gBC5MC6 
To generate gBC5MC6, an Asp718 restriction site was introduced by site-
directed mutagenesis in gBC6 with primer 5’ TCATGGTGCAGAGGTAC 
CGGCGCTTTGGCAC. The mutagenesis inserted the following substitutions: 
P361R, S362Y and V363L. 
h) gBC6C7 
To generate gBC6C7 an EcorV restriction site was inserted in gBC6. The 
site-directed mutagenesis was performed with primer 5’ CGCGTGG 
TGCGATATCCAGAATCACGAGCTG and introduced the substitutions 
E530D and L531I. 
i) gBC4C5 
Asp718 and HpaI restriction sites were inserted at aa 362 and aa 270 
respectively, by site-directed mutagenesis of gB5E1N∆867 with primers 
previously described in c) and g). 
 j) gB13H8 
To generate gB13H8, the sequence encoding amino acid residues 65 to 167 
of HHV8-gB was PCR amplified from plasmid pAB38 that carries HHV8-
gB in pcDNA3.1(-)Myc/HisA vector (gift of F. Neipel), with primers  
5’TTTTAAAGCTTCAGAGTGTGTAGTGC and 5’AGTAAATGTGTTTTCTAG 
ACCGTTG.  
The amplified fragment was digested with HindIII and XbaI and cloned 
into gBC1C3C4 digested with the same endonucleases. 
k) gB34H8 
To generate gB34H8, the sequence encoding amino acids 169 to 221 of 
HHV8-gB was PCR amplified from plasmid pAB38 with the primer pairs 
5’CAACGGTCTAGAAAACACATTTACTGAC plus 5’AACGGTGGTCCTAACTC 
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TGTATATGCC that was phosphorylated at its 3’ end. The amplimer was 
digested with XhoI and cloned into gBC3C4 digested with XhoI and HpaI. 
l) gB45H8 
To generate gB45H8, the sequence encoding amino acids 223 to 311 of 
HHV8-gB was PCR amplified from plasmid pAB38 with primers 5’ CCG 
TTAACTGCGAGATAGTCGACATGAT and 5’ CACAGGTACCTGGTCTTGC 
TCTCGGA. The amplified fragment was digested with HpaI and Asp718 
and ligated in HpaI/Asp718-predigested gBC4C5.  
m) gB56H8 
The construction of gB56H8 followed essentially the same strategy. The 
sequence encoding amino acid residues 316 to 361 of HHV8-gB was PCR 
amplified from plasmid pAB38 with primers 5’ GACCAGGTACC 
TGTGTCCGCTAGCACTGTGG and 5’CCGACTCGAGACAAGAGTACGTGT 
CGGTAAA. The amplimer was digested with Asp718 and XhoI and cloned 
into gBC5MC6 digested with the same endonucleases. 
n) gB67H8 
To generate gB67H8, the sequence encoding amino acids 365 to 485 of 
HHV8-gB was PCR amplified from plasmid pAB38 with primers 5’ 
CTCTTGTCTCGAGTCGGATATCAACAC and 5’ GTCCCTGACCTGAGGCCTA 
CACCAT. The amplimer was digested with XhoI and StuI and ligated in 
gBC6C7 peviously digested with XhoI and EcorV. 
 
3.2.4 Generation of plasmids useful for pull down experiments 
To generate gHStrep an amplimer that carried the sequence encoding the V5-
epitope, the One-STrEPTM tag (trademark of IBA GmbH) and the factor Xa 
Protease recognition site, was generated by extension of two synthetic 
partially overlapping oligonucleotides: 5’ GGAGACGCATGCTAATCGAAG 
GGCGAGGTAAGCCTATCCCTAACCCTCTCCTAGGCCTCGATTCTACGAGCGCTT
GGAGC-3’ and  5’GGTAGTAGATCTCATTTTTCGAACTGCGGGTGGCTCCACGA 
TCCACCTCCCGATCCACCTCCGGAACCTCCACCTTTCTC-3’. The fragment was 
digested with SphI and BglII and cloned into plasmid gH5E1 predigested with 
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the same endonucleases. gH5E1 plasmid (gift of Gianni T.) encodes HSV-gH 
with a 5E1-epitope inserted in frame at residue 837. The amplimer inserted 
replaced 5E1-epitope.  
5E1-epitope was displaced from gH5E1 also by V5 epitope to generate gHV5. 
An amplimer encoding the epitope V5 and the His-Tag was obtained by 
extension of the partially overlapping oligonucleotides: 
5’GGAGACGCATGCTAGGATCCGGTAAGCCTATCCCTAACCCTCTCCTCGGTCT
CGATTCTACGC and 5’TTAGCGAGATCTCAATGGTGATGATGGTGATGATGA 
ACGGTACGCGTAGAATCGAGACCGAGGAGA. The fragment was digested with 
SphI and BglII and cloned into predigested gH5E1. The construct obtained was 
named gHV5. 
To construct gDStrep , an amplimer that carried the sequence encoding One-
STrEP TagTM was generated by extension of the partially overlapping primers 
5’GGAAGATCTCTGGCTGGAGCCACCCGCAGTTCGAGAAAGGTGGAGGTTCCG
GATCGGGAGGTGGATCG and 5’CCCAAGCTTCCCGGATCCTCATTTTTCGAAC 
TGCGGGTGGCTCCACGATCCACCTCCCGATCCGGAACCT. The amplimer was 
digested with BglII and HindIII and ligated in BglII/HindIII-digested gDN 
(see chapter 3.2.1). 
 
3.3 OTHER PLASMIDS   
 
pEA99 carries the gD gene cloned in pcDNA 3.1(-) [134].   
The gB, gH, and gL genes were cloned in pMTS-1, a vector derived from 
pAcSG2 (Pharmingen) by the insertion of CMV IE promoter [11 and 47]. 
gLV5 encodes for gL with V5 epitope fused at C-terminus. gB in pcDNA3.1 
contained a StuI/BglII fragment subcloned from gB in pMTS-1. EGFR2∆ 
(named Erb-2) carries the extracellular domain and transmembrane sequences 
of rat HER-2/neu and is deleted of the tyrosine kinase domain [135]. Plasmid 
pCAGT7 containing the T7 RNA polymerase gene under control of the CAG 
promoter, and the pT7EMCLuc plasmid expressing the firefly luciferase 
under the T7 promoter were decribed in ref. [79 and 136]. pCF18 carries 
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nectin1β cDNA, cloned into BstXI and NotI of pcDNA3.1(+) [33]. pBEC10 
encoding HVEM was described in ref. 25. pcDNA3.1(-)Myc-His/Lac vector 
(Invitrogen, Milan, Italy), encodes βgalactosidase.  
 
 
3.4 ANTIBODIES 
 
Monoclonal antibody (MAb) H170 is directed to the N-terminal of gD 
(Goodwin Institute, Plantation, FL and ref. 137). Polyclonal antibody (PAb) R8 
is directed to gD [138]. MAb H1817 is directed to the first 20 residues of gB 
ectodomain, the latter at the N-terminus (Goodwin Institute, Plantation, FL and 
ref. 139). MAb 53S recognizes a discontinuous epitope of gH and strictly 
requires gL for reactivity [137].  
MAb R1.302 is directed to hNectin-1 (gift of M. Lopez) [140]. H633 to gC was 
from Goodwin Institute (Plantation, FL). Anti-V5 antibody was from Invitrogen 
(Milan, Italy) and was used to recognize gHV5 and gLV5. Monoclonal antibody 
5E1 is an HHV-7-specific MAb directed to pp85(U14) herein used to recognize 
gB5E1N and other gB-mutants in which the specific epitope was inserted. 
Anti-rabbit or anti-mouse IgG-FITC (fluorescin-isothiocyanate) or -TRITC 
(tetra-methyl-rhodamine isothiocyanate) conjugated antibodies were from 
Jackson Immunoresearch. Coupled to peroxidase anti-mouse and anti rabbit 
secondary antibodies were from Sigma-Aldrich or GE Healthcare. 
 
 
3.5 INDIRECT IMMUNOFLUORESCENCE (IFA)  
 
COS cells were grown on glass coverslips and transfected with the indicated 
plasmids by means of Polyfect (Qiagen), according to manufacturers 
instructions. 293T cells were transfected by means of Arrest-in 
(OpenBiosystem, Celbio, Milan, Italy). After 24 h the cells were fixed with 
either 4% paraformaldehyde in PBS for 10 min at room temperature followed, 
when requested,  by permeabilization with 0.1%Triton X-100  in phosphate-
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buffer saline (PBS), or fixed with -20°C-cold methanol. Samples were incubated 
for 1h with the following monoclonal antibodies (MAbs): MAb H170 (1:400) to 
gD; MAb 53S (1:200) to gH; MAb R1.302 to nectin-1 (1:100); MAb H1817 
(1:400) to gB. Alterwards, the appropriate anti-mouse or anti-rabbit IgG-FICT 
(fluorescein-isothiocyanate) conjugated antibody (1:1000) (Jackson 
Immunoresearch) was added and incubate for 45 minutes. Samples were 
observed with a Zeiss microscope, and micrographs were taken with a Kodak 
DC290 digital camera.  
 
3.6 SPLIT EGFP COMPLEMENTATION ASSAY 
 
COS or 293T cells were grown on glass coverslips and transfected with the 
indicated combination of plasmids gDN, NectC, gHC, gHN, gBC, and gCC by 
means of Arrest-in (OpenBiosystem, Celbio, Milan, Italy). At 24-48 h post 
transfection cells were mounted without fixation with Fluoromount and 
observed with Leica TCS-SL confocal microscope, set at 100% excitation at 
488 nm and emission between 490-540 nm. Images were collected with a 
63X1.62 Leica oil immersion objective. Confocal slices were 1.7 to 2.3 µm 
thick. For each experimental series images were collected on the same day, 
under the same settings, applying 1,024- by 1,024-pixel resolution and an 8-
bit intensity scale. Specifically, the first sample to be analyzed was the 
negative one, containing gCc; for subsequent observations of the samples 
belonging to the same series, the settings were then kept unmodified. 
 
3.7 CELISA (cell enzyme linked immunosorbent assay) 
 
CELISA was performed as described [141]. Briefly, subconfluent cultures of 
COS cells in 48-well plates were transfected with plasmids encoding wt-gD 
or gD mutants (125, 250, or 375 ng per well), or with 125 ng of plasmids 
encoding  wt-gB or gB mutants. The Erb-2 plasmid DNA was used to make 
the amounts of DNA equal. After 24 h cells expressing gD were reacted with 
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MAb H170, HVEMt, or nectin 1-Fc and cells expressing gB were reacted 
with MAb H1817 .  Subsequently, cells were fixed with 4% formaldehyde in 
PBS, followed by anti-mouse peroxidase, anti-His6-peroxidase, or anti-human 
peroxidase and o-phenylenediamine substrate. The optical density (OD) was 
read at 490 nm.  
 
 
3.8  CELL-CELL FUSION ASSAY 
 
 β-galactosidase-based cell–cell fusion assay 
Subconfluent cultures of BHK cells, grown on glass coverslips in 24 well plates, 
were transfected by means of Fugene (Roche Applied Science, Milan, Italy) 
with DNA mixtures that contained the expression plasmids for gD, gH, gL, gB, 
plus pcDNA 3.1(-) Myc-His/Lac vector (Invitrogen, Italy), for constitutive 
expression of ß-Galactosidase (80 ng of each plasmid). When necessary the wt-
gB was replaced with gB mutants or Erb-2. After incubation at 37° for 48 h, 
cells were fixed with 0.2% glutaraldehyde and 0.2% paraformaldehyde in PBS. 
Syncytia were detected by light microscopy observation of ß-Gal expressing 
cells after staining with 5-bromo-4chloro-3-indolyl-ß-galactopyranoside (X-Gal) 
with a Axioplan Zeiss microscope equipped with a Kodak DC120 digital 
camera.  
 Luciferase-based cell-cell fusion assay 
The luciferase-based cell-cell fusion assay was performed as detailed [141] 
using the Luciferase Assay System from Promega. Effector COS cells were 
transfected with 80 ng of plasmids for gH, gL, gB, plus 80 or 240 ng of plasmid 
for  chimeric or WT-gD or Erb-2 and 107 ng of pCAGT7. Target cells [COS, J-
nectin 1, and J-HVEM were transfected with pT7EMCLuc. The extent of fusion 
was express as luciferase units (L.U.) reading the sample in a luminometer TD-
20/20 (Turner designs version 2.5) at 560 nm. The negative control lacked gD 
and its value was the subctracted background. The total amount of transfected 
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plasmid DNA was made equal by addition Erb-2 plasmid DNA. All samples 
were run three times and in triplicates. 
 
3.9 INFECTIVITY COMPLEMENTATION ASSAY 
 
Cells in T25 flasks were transfected by means of Polyfect (Qiagen) with the 
indicated plasmids.  The total amount of plasmid DNA transfected per flask was 
made equal by addition Erb-2 plasmid DNA.  Four h later cells were infected 
with with gD-/+ FgDβ (3 PFU/cell). Unpenetrated virions were inactivated by 
washing two times with PBS, followed by a 1 min rinse with 40 mM sodium 
citrate, 10mM KCl, 135 mM NaCl, pH 3. The monolayers were then rinsed 
twice with PBS and overlaid with medium containing 1% FBS and frozen 24 h 
after transfection. Progeny virus was titrated in gD-expressing cells (R6) or was 
quantified as β-galactosidase activity in BHK, J-nec1, or J-HVEM cells by 
staining with o-nitrophenyl-β-D-galactopyranoside (ONPG) and reading the 
optical density (OD) at 405 nm or by light microscopy observation of β-gal-
expressing cells after staining with X-gal. 
Infectivity complementation assay of gB-/+ K∆T virus followed esentially the 
same protocol but progeny virus was titrated in gB-expressing cells (D6) 
 
3.10 STREP-TAG PULL DOWN EXPERIMENTS AND WESTERN BLOT 
ANALYSIS 
293T cells (∼2,8 x 106 cells/T25 flask) were transfected by means Arrest-in 
(OpenBiosystem, Celbio, Milan, Italy) with plasmids encoding gHV5, gLV5, 
gB5E1ND867, gD (1,5 µg each, all together or combination of them) and HVEM (3 
µg) or when necessary gB5E1ND867 was replaced with HSV-HHV8 gB chimeras, 
wt-gD with gDSTREP or gHV5 with gHSTREP. 24 h after transfection cells were 
solubilized in EA1+ (250 mM NaCl, 50 mM hydroxyethylpiperazine-
ethanesulfonic acid and 0,1% Nonidet P40, pH 8)  added with Nα-p-Tosyl-L-
lysine chloromethyl ketone hydrochloride (TLCK) and N-p-Tosyl-L-
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phenylalanine chloromethyl ketone (TPCK) (final concentration 0,3 mM each). 
Cell lysates were centrifuged at 14000 rpm for 1h. The supernatants were 
incubated with Protein A-Sepharose resin (Sigma Aldrich, Milan, Italy) for 1 h 
at 4 °C. After incubation the beads were recovered by centrifugation and then 
the complexes were harvested by incubation with the Strep-Tactin Sepharose 
(IBA GmbH, Gottingen, Germany) 1 h at 4 °C with gentle mixing. Strep-Tactin 
is  an engineered streptavidin [142]. The beads were washed five times with 
Buffer W (100 mM Tris-Cl pH 8.0, 150 mM NaCl and 1 mM EDTA) and then 
the absorbed proteins were eluted by the addition of SS (solubilizing solution) 
containing SDS and β-mercaptoethanol. The proteins were separated by 
denaturing polyacrylamide gel electrophoresis (PAGE) and transferred to 
Hybond ECL nitrocellulose membrane (Amersham Biosciences, Milan, Italy). 
The membranes were blocked 1 h at RT with ECL Advance Blocking Agent 
(GE Healthcare, Milan, Italy) incubated overnight with the appropriate antybody 
and then with anti-mouse or anti-rabbit peroxidase-conjugated antibody 
(1:80000) (GE Healthcare, Milan, Italy). The blot was developed by ECL 
Advanced Western Blotting Detection Kit (GE Healthcare, Milan, Italy), 
according to manufacturer’s instructions. 
 
3.11 BIOINFORMATIC ANALYSIS 
 
The sequences of HVS-HHV8 chimeras were submitted to SWISS-MODEL 
server (http://swissmodel.expasy.org//SWISS-MODEL.htm). SWISS-MODEL 
provides a fully automated comparative protein modelling service. To build the 
homology model, SWISS-MODEL identified a structural template, aligned the 
target sequence and the template structure, generated the model and minimized 
the energy of the model. For each steps SWISS-MODEL used specialized 
software and protein databases. SWISS-MODEL also provided a model quality 
evaluation [143].  
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depicted as geometrical drawings (yellow and blue). In d) is represented the EGFP recostitution after proteins 
interactions (modified from ref.146). 
4. RESULTS, DISCUSSION AND 
CONCLUSIONS 
 
 
 
4.1 DEVELOPMENT OF A SPLIT EGFP 
COMPLEMENTATION ASSAY TO DETECT INTERACTION 
BETWEEN gD, gB, gH.gL 
 
4.1.1 RESULTS 
4.1.1.1 gD-Nectin1 complex detection.  
To investigate HSV glycoproteins interaction we used the split enhanced green 
fluorescent protein (EGFP) complementation assay. EGFP is a humanized red-
shifted variant of wilde type GFP from Aquorea victoria, incorporating mutation 
for optimal expression in mammalian cells and brighter fluorescence. EGFP is 
composed of 11 strands of β sheet that form an anti-parallel barrel with short α 
helices forming lids in each end. The fluorescent-active center of EGFP is 
located inside the barrel. In the complementation assay (CA), EGFP is split into 
two fragments  that, if brought to an 8- to 10-Å proximity of ach other, refold 
together and emit fluorescence [144 and 145] Fig. 4.1.1 
 
 
 
Fig. 4.1.1 Schematic of EGFP dissection. In a) a schematic of the secondary structure topology of EGFP is 
shown and the site of dissection is indicate. In b)c) and d) the interaction partners fused to EGFP fragments are 
a
b
d) 
c)
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Inasmuch EGFP-CA has been applied mainly to analysis of soluble mammalian 
or bacterial proteins [144], we first validated its application to membrane proteins 
- in particular to HSV glycoproteins - by analysis of gD and its nectin1 receptor. 
We fused the N- and C- fragments of EGFP (EGFP N-term corresponds to aa 1-
157 and C-term corresponds to aa 158-239) to the endodomains of gD and 
nectin1 respectively, the constructs were named gDN and NectC. Fig. 4.1.2 C and 
M, documents complex formation between gDN and NectC as fluorescence 
emission from EGFP-CA in transfected 293T and COS cells, and the specificity 
controls. Cells were observed 36 h after Arrest-in-mediated transfection. Results 
with the two cell lines were essentially similar, although the level of expression 
and number of fluorescent cells was higher in 293T cells. In agreement with 
previous reports, the overall fluorescence emitted by complementation of split 
EFGP fragments was lower than that from the unsplit protein [144]. The 
specificity controls that validated the assay were as follows. First, neither gDN  
nor NectC emitted fluorescence when transfected singly (Fig. 4.1.2 A, B, K, L), 
or in combination with the wt alleles of nectin1 or gD (not shown), ruling out 
autofluorescence. Second, fluorescence was reconstituted only when the EGFP 
chimeric proteins were in a specific complex, and not simply present in the same 
subcellular compartment. For this control, we selected gC, which is involved in 
virus attachment but not virus entry and is present in the same subcellular 
compartments as gD. Coexpression of gDN and gCC  resulted in no significant 
fluorescence (Fig. 4.1.2 D and N), ruling out the possibility that proteins that 
exhibit no specific interaction, but that are abundantly present in the same 
cellular compartment, give rise to EGFP complementation. We took advantage 
of the lack of EGFP complementation by gCC-containing samples and, in all 
experiments, used the gCC-containing sample to adjust the confocal microscope 
settings. The settings were then kept constant throughout the observation period 
of a same series of samples. Third, we ascertained by immunofluorescence assay 
(IFA) that all proteins were expressed, even those expressed singly (gDN, NectC) 
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(Fig. 4.1.2 E, F, O, and P) or in the gDN-gCC combination that did not yield 
EGFP fluorescence (Fig. 4.1.2 I, J, S, and T).  
  
 
FIG. 4.1.2 EGFP CA (A to D and K to N,) and IFA (E to J, and O to T). EGFP CA between gDN and NectC and 
lack of complementation between gDN and gCC. COS or 239T cells were transfected with the indicated plasmids, 
gDN (A, E, K, and O), NectC (B, F, L, and P), gDN_NectC (C, G, H, M, Q, and R), and gDN_gCC (D, I, J, N, S, 
and T). IFA: Green, gD; red, NecC or gCC. Antibodies used were R8 to gD, R1.302 to nectin1 and H633 to gC. 
 
 
Importantly, the EGFP-glycoprotein chimeras were not hampered in plasma 
membrane localization (Fig. 4.1.2). We conclude that EGFP-CA fulfills the 
criteria for detection of specific interactions between membrane-bound proteins, 
particularly HSV gD and its receptor.  
 
4.1.1.2 Complexes between HSV glycoproteins. 
The second series of experiments was performed with 293T and COS cells 
tranfected with three membrane proteins in combinations that included: 
gDN+gBC, gDN+gB∆867, gDN+gHC+wtgL, gDN+wtgH+wtgL, and gDN+gCC. We 
used a form of gB deleted for endocytosis motifs, to maximize its espression and 
localization in exocytic and plasma membranes [73]. Transfection mixtures were 
made equal in DNA amounts (900 ng/well, 300 ng/plasmid) by addition of 
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plasmid encoding epidermal growth factor receptor 1 deleted in signalling 
sequences [135]. This control ensured that exocytic membranes were loaded 
with comparable amounts of proteins. In both cell types observed 36 h after 
transfection, the gDN+gHC+wtgL combination resulted in a readily detectable 
fluorescence (Fig. 4.1.3 B and E). The gDN+gBC combination gave rise to a 
somewhat weaker fluorescence (Fig. 4.1.3 A and  D) that nonetheless was much 
higher than the background fluorescence emitted by the gDN+gCC combination 
(Fig. 4.1.3 C and F). Even though the subcellular localization cannot be clearly 
defined, EGFP appeared to localize to a perinuclear position, consistent with a 
Golgi compartment localization, to a cytoplasmic reticular compartment, 
consistent with endoplasmic reticulum, and to nuclear membranes. By IFA, all 
proteins resulted to be expressed, even those that did not yield EGFP 
fluorescence (not shown). We infer that gD can recruit gH to a complex. gD can 
also recruit gB to a complex. The gD-gH combination results in a stronger EGFP 
fluorescence than the gD-gB combination, possibly reflecting a stronger 
interaction, a more stable or longer half-life complex, a higher number of 
complexes at steady state, or peculiar behaviors of the fusion proteins. 
Cells transfected with the quartet of gD, gB, gH, and gL form syncytia [79]. A 
series of experiments was designed to verify whether the glycoprotein-EGFP 
chimeras were still functional in cell-cell fusion, and whether complexes were 
detectable under conditions that lead to cell-cell fusion. 293T or COS cells were 
cotransfected with combinations of five plasmids (1.25 µg/well, 250 ng/plasmid) 
encoding gD, gB 867, gH, gL, and gC or their EGFP chimeras. The transfected 
combinations included gDN+gBC+wtgH+wtgL+wtgC, gDN+gHC+wtgL+gB
867+wtgC, and gDN+gB 867+wtgH+wtgL+gCC. Cells were observed 24 h (293T) 
or 40 h (COS) after transfection. The results in Fig. 4.1.3 G to L show that 
syncytia were formed for any combination, indicating that the EGPF-
glycoprotein chimeras were not hampered in fusion activity. The strongest 
fluorescence was observed with the combination that included gDN+gHC (panels 
H and K).  
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FIG. 4.1.3. EGFP CA between HSV glycoproteins. COS or 239T cells were transfected with the indicated 
plasmids, gDN + gBC (A, D, G, and J), gDN + gHC (B, E, H, and K), gDN + gCC (C, F, I, and L), gHN + gBC (M 
and O), and gHN + gBC + gD (N and P). Cells transfected with three glycoproteins (gps) received, in addition, 
plasmids encoding wtgL or epidermal growth factor receptor, as appropriate. Cells transfected with five 
glycoproteins received gD, gB∆867, gH, gL, and gC as the wild type or EGFP chimeras, as indicated. 
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A somewhat weaker fluorescence was observed with the combination that 
included gDN+gBC (panels G and J), particularly in COS cells. No fluorescence 
above background level was observed with the combinations that included 
gDN+gCC (panels I and L).  
The stronger fluorescence in panels B relative to H and in panels E relative to K 
reflects (i) higher amounts of transfected DNA for each plasmid, (ii) a longer 
time interval after transfection (panels B versus H), (iii) the lack of dilution of 
complemented EGFP molecules consequent to fusion of transfected fluorescent 
cells with adjacent untransfected nonfluorescent cells, or (iv) possibly a longer 
half-life of the complexes when cell-cell fusion does not ensue. 
We next tested whether gH and gB interact with each other and whether the 
interaction was dependent on the presence of gD. Cells were transfected with 
gHN+wtgL+gBC in the absence or presence of wtgD. Interaction between gHN-
gBC (Fig. 4.1.3 M and O) of gD. 
 
4.1.2 CONCLUSIONS 
We validated the adaptation of the EGFP-CA to membrane proteins by first 
applying it to the gD-nectin1 interaction. The fluorescence emitted from the 
gDN-NectC combination was readily detectable, whereas that from the gDN-gCC 
combination was detected at only background levels, testifying to the assay 
specificity. For every series of observations, the gCC-containing sample was 
therefore used to adjust the confocal microscope settings. Samples exhibiting 
readily detectable fluorescence under these conditions were considered positive. 
We detected a complex made of gD and gH, in agreement with 
coimmunoprecipitation data [40]. The complex formed even in the absence of 
gB. In addition, we detected a complex made of gD and gB that formed even in 
the absence of gH·gL. We further documented the interaction between gH and 
gB; its gD dependence suggests that the interaction is triggered by gD. A notable 
property of the EGFP-CA as applied here was that complex formation between 
HSV glycoproteins was detected in intact cells, i.e., in the intracellular 
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compartment and microenvironment and under the very conditions in which the 
interactions do occur. Importantly, the EGFP chimeric glycoproteins were not 
hampered in cell-cell fusion activity. Hence, the detected interactions were a 
faithful mirror of the interactions that take place under conditions that lead to 
cell-cell fusion. Inasmuch as EGFP reconstitution from split portions is an 
irreversible reaction, the assay does not allow us to infer whether the complexes 
between the HSV glycoproteins were stable or transient.  
Cumulatively, the current assay provides in situ evidence for the following.  
(i)  gD recruits gH·gL and gB to complexes.  
(ii)  gH and gB can be recruited to gD independently of one another. Thus, 
gD carries binding sites for both gH·gL and gB. The independent 
recruitment of these glycoproteins to gD is consistent with and 
substantiated by the observation that, at the outer nuclear membrane, 
virions deleted for gB but carrying gD+gH, or deleted for gH but 
carrying gD+gB are capable of fusion [101].  
(iii)  Once gH·gL and gB are recruited to gD, they possibly interact with each 
other. (iv) gH·gL and gB are not necessarily recruited in a sequential 
order or one to the other. Current data support a model of HSV entry-
fusion whereby gH and gB exert their activity through complex 
formation with gD, or following activation mediated by complex 
formation with gD.  
 
4.2 ROLE OF gD PRO-FUSION DOMAIN IN THE 
RECRUITMENT\ACTIVATION OF gB AND gH.gL 
 
4.2.1 RESULTS 
4.2.1.1 Functional Subdomains in gD-PFD.  
To identify functional subdomains of PFD, we generated two gD chimeric 
proteins that carried, downstream of residue 259, either PFD/1 (amino acids 260-
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285) or PFD/2 (amino acids 285-310) (Fig. 4.2.1). In the constructs, gD-PFD/1 
and gD-PFD/2, the TM and C-tail regions were from gD, and the gD missing 
sequences were replaced by the corresponding sequence of CD8. A chimera in 
which the entire PFD was replaced by the corresponding sequences of CD8 
(gD∆PFD) differed from gD(1-260)CD8 [53] in that the TM and C-tail regions were 
from gD but not from CD8. The chimeric forms of gD, cloned in pcDNA3.1(-), 
were analyzed for their ability to reach the plasma membrane, and in three 
functional assays, i.e., the binding to soluble forms of HVEM (HVEMt) and 
nectin 1 (nectin 1-Fc) [33 and 38], the cell-cell fusion, and the infectivity 
complementation. All chimeric gDs reached the plasma membrane as measured 
by CELISA (Fig. 4.2.2) and by immunofluorescence of paraformaldehyde-fixed 
cells (data not shown). In the case of gD-PFD/2, 3-fold higher amounts of 
plasmid (3×) were transfected to achieve a WT level of plasma membrane 
expression; gD-PFD/2 was transfected at 3× higher concentrations relative to 
WT-gD in all subsequent experiments, except when otherwise stated. The binding 
to HVEMt and nectin 1-Fc, measured by CELISA, showed an extent of binding 
similar to that of WT-gD (Fig. 4.2.3). 
For the cell-cell fusion assay, baby hamster kidney cells were cotransfected with 
the gD-PFD chimera or WT-gD plus gB, gH, gL, and β-galactosidase plasmids 
[73, 79] and were stained with 5-bromo-4-chloro-3-indolyl β-galactopyranoside 
(data not shown). For the luciferase-based cell-cell fusion assay [141], each 
chimeric gD or WT-gD was cotransfected with gB, gH, gL, and the T7 
polymerase in COS cells. The target COS, J-nectin 1, or J-HVEM cells were 
transfected with a T7-promoter-driven luciferase gene; COS cells were 
transfected at either 1× or 3× the amounts of plasmids (Fig. 4.2.4A). The two 
assays concordantly showed that gD-PFD/1 was partially active in the fusion 
assay; the activity increased when the plasmid amounts were increased 3×. By 
contrast, gD-PFD/2 was inactive at either concentration. gD∆PFD was inactive at 
either concentration, in accordance with the analogous gD(1-260)CD8 [53]. The 
results suggest a certain degree of differentiation in fusion activity between the 
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two PFD subdomains, and only subdomain 1 was in part sufficient for this 
function, in agreement with ref. 149. 
Next, we determined whether the same chimeric forms of gD were capable of 
complementing infectivity. Each chimera, or WT-gD, was transfected into COS 
cells, and 4 h later, the cells were infected with the gD-deletion virus FgDβ [131]. 
When the virus is grown in noncomplementing cells, noninfectious gD-/- progeny 
are produced. When the virus is grown in cells expressing gD, gD complements 
the virus (gD-/+ stock) and confers infectivity. If gD is partially defective, the 
complemented virions exhibit a reduced infectivity. As shown in Fig. 4.2.4B, gD-
PFD/1 was partially active in the infectivity complementation, consistent with the 
partial cell-fusion activity. The complementation activity did not change whether 
the gD-PFD/1-encoding plasmid was transfected at 1× or 3× amounts (data not 
shown). Surprisingly, gD-PFD/2, which exhibited no cell-fusion activity, partially 
complemented infectivity. Similar results were obtained irrespective of the cell 
line and of the receptor expressed in the cells where the complemented virions 
were titrated. The results indicate that PFD cannot be narrowed down, because 
subdomain 1 (amino acids 260-285) exhibits partial cell fusion and infectivity 
activities. The subdomain 2 (amino acids 286-310) is not sufficient for cell fusion 
but is sufficient for partial complementation of infectivity, in agreement with the 
finding that Pro residues 288, 291, 292, and 305 were critical residues for 
infectivity [53]. The discrepancy between the results of the cell-cell fusion and 
infectivity complementation assays indicates that the two assays mirror each other 
but are not necessarily identical. 
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Fig. 4.2.1 Schematic diagram of gD constructs. At the top, linear map of WT-gD, with N terminus (amino acids 
1–260) carrying receptor-binding sites (orange) and C terminus (amino acids 260–310) carrying the PFD 
(yellow), the transmembrane (TM) (black), and the C-tail (green) regions. The black bold line in the chimeras 
represent the region of gD replaced by sequence derived from CD8. 
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Fig. 4.2.2 Cell surface expression of gD chimeric proteins quantified by CELISA. 
COS cells, in 48 wells, were transfected with plasmids encoding wt or chimeric forms of gD at the indicated 
amounts, corresponding to 1x, 2x, or 3x the regular amount. Cells were fixed with 4% paraformaldehyde at 24 h 
after transfection and were reacted with mAb H170, anti-mouse IgG peroxidase, and o-phenylenediamine. 
Results are expressed as peroxidase units (P.U.). Vertical bars denote SD. Columns represent the average of 
triplicates. Three independent experiments were run. 
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Fig. 4.2.3 Binding of COS cells expressing the chimeric or WT-gD to HVEMt and nectin 
1-Fc. Details were as in Fig. 4.2.2, except that cells were reacted with the soluble receptors, anti-His6-peroxidase 
or anti-human peroxidase, to detect HVEMt and nectin1-Fc, respectively, and o-phenylenediamine.  
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Fig. 4.2.4 Cell– cell fusion and infectivity complementation of chimeric gD proteins. a) Luciferase-based 
cell–cell fusion assay. Effector COS cells, in 24 well-plate, were transfected with 80 ng/well of plasmids 
encoding gH, gL, gB, 107 ng/well of plasmid encoding T7 polymerase and  80 or 240 ng of plasmids encoding 
chimeric or wt-gD, corresponding to 1X and 3X regular amounts. Target cells [COS, J-nectin 1 (J-Nec1), and J-
HVEM] were transfected with T7-luciferase-expressing plasmid. The negative control lacked gD (data not 
shown). The luciferase activity was expressed as luciferase units (L.U.). b) Infectivity complementation. COS 
cells were transfected with chimeric or wt-gD and infected 4 h later with a gD stock of FgDβ (3 PFU/cell). 
Progeny virus was titrated at 24 h in gD-expressing cells (R6) or was quantified as β−galactosidase in BHK, J-
nec1, or J-HVEM cells.  
 
 
 
 
 
  65
.2.1.2 Effects of Pro and Glu Substitutions in Subdomain 1.  
sidues, most of 
rolines present in PFD sequence are highlighted red, other residues mutated are highlighted blue. The amino 
4
The PFD sequence (Fig. 4.2.5) reveals a high content of Pro re
which are adjacent to Glu residues in PFD/1. Some prolines in PFD/2 (amino 
acids 288, 291, 292, and 305) are critical for infectivity [53]. Here, the prolines of 
PFD/1 were replaced by leucines and the glutamic acids by alanine residues (both 
are nonconservative substitutions). The mutants 1-4 carried the following 
substitutions, E259A-P261L, PE266-267LA, PE270-271LA, and PED273-274-
275LAA, respectively. Their cell-surface expression, as determinated by 
CELISA, showed no major defect (Fig. 4.2.6A). In the infectivity 
complementation, none of the mutants exhibited a significant defect (Fig. 4.2.6B). 
The cell-cell fusion activity of mutant 1 was increased by 20 %, whereas that of 
mutants 2-4 was reduced by 20-25% (Fig. 4.2.6C). Thus, the Pro and Glu residues 
do not represent critical residues in PFD/1. 
 
 
 
 
Fig. 4.2.5 a) Schematic diagram of gD. b) The pro-fusion domain (PFD) sequence is shown on the top. All 
wt
--260-------270-------280-------290-------300-----308
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Fig.4.1.2B a) Cell surface expression of gD mutants quantified by CELISA. COS cells, were transfected with 
125 ng of plasmids encoding wt or mutagenized forms of gD. Cells were fixed with 4% paraformaldehyde at 24 
h after transfection and were reacted with mAb H170, anti-mouse IgG peroxidase, and o-phenylenediamine. 
Results are expressed as peroxidase units (P.U.) b) Infectivity complementation. COS cells were transfected 
with mutagenized or wt-gD and infected 4 h later with a gD stock of FgDβ (3 PFU/cell). Progeny virus was 
titrated at 24 h in gD-expressing cells (R6). c) Luciferase-based cell–cell fusion assay. Effector COS cells, seed 
in 24 well-plate, were transfected with 80 ng /well of plasmids encoding gH, gL, gB, and wt or mutagenized gD, 
plus  107 ng/well of plasmid encoding T7 polymerase. Target COS cells were transfected with T7-luciferase 
expressing plasmid. The negative control lacked gD (data not shown). The luciferase activity was expressed as 
luciferase units (L.U.).  
 
 
4.2.2 CONCLUSIONS 
PFD of HSV-1 gD is made of subdomains 1 and 2, comprising residues 260-285 
and 285-310, respectively. Each subdomain partially contributed to virus entry, 
whereas only the subdomain 1 exhibited cell-cell fusion activity. The latter 
finding is in agreement with the report of Zago et al. [147]. Mutational analysis of 
Pro and Glu, the most characteristic sequence pattern of subdomain 1, did not 
highlight any critical role of these amino acids in the infectivity complementation 
and resulted in a modest reduction in the cell-cell fusion assay. The lack of 
phenotype of these mutants is in agreement with the observation that serial 5-aa 
deletions in this region failed to identify a specific sequence requirement [147]. 
The properties of the PFD/1 subdomain contrast with those of PFD/2, which 
carries some Pro that is critical for infectivity [53]. Their mutagenesis did not 
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alter PFD-binding to gD N terminus, implying a role at subsequent steps, likely in 
the triggering of fusion. 
 
 
4.3 INTERACTION OF gB MUTANTS WITH gD AND gH, 
DETECTED BY MEANS OF PULL DOWN EXPERIMENTS 
 
4.3.1 RESULTS 
4.3.1.1 Generation of gB backbones.   
Insertion of 5E1 epitope and deletion of part of the C-tail encoding 
endocytosis motifs. 
To enable gB detection, we inserted an heterologous epitope, named 5E1 
epitope, recognized by a specific MAb [133]. The epitope was inserted between 
aa 68 to 77, a poly-lysine domain known to be deletable. The resulting construct 
was gB5E1N (Fig.4.3.1). The details of the constructions are given in M&M. 
Essentially, two restriction sites, BamHI and EcoRI, were inserted at residues 68 
and 77, respectively, by site-directed mutagenesis. An amplimer was generated 
by extension of two synthetic partially overlapping oligonucleotides, cleaved 
with BamHI and EcoRI, and ligated in predigested gB.  
Avitavile et al showed that removal of part of the cytoplasmic tail of gB 
encoding the endocytosis motifs results in a form of gB that exhibits a cell 
surface expression and, consequently, increased cell-cell fusion activity [73]. 
Here, removal of the endocytosis motifs located in the cytoplasmic tail, 
downstream of aa 867, was performed by insertion of a stop codon at aa 867 by 
site directed mutagenesis. The resulting construct was named gB5E1N∆867. Fig. 
4.3.2 and 4.3.3 show that, as expected, gB5E1N∆867 exhibited a higher cell surface 
expression and fusion activity than wt-gB and gB5E1N. 
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Fig 4.3.1 Schematic representation of HSV-1 gB. The top drawing depicts the domain architecture observed in 
the crystal structure of wt gB [84] and the locations of highly conserved cysteines. The bottom two lines show 
the modifications introduced to construct gB5E1N and gB5E1N∆867. 
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Fig.4.3.2 On the left cell surface expression quantified by CELISA. COS cells seeded in 48 well-plate were 
transfected with 125 ng per well of the plasmids encoding wt gB or gB5E1N or gB5E1ND867. 24 hours later 
cells were reacted with mAb H1817 and then  fixed with 4% formaldehyde in PBS, followed by incubation with 
anti-mouse peroxidase and o-phenylenediamine. Background value was subtracted. Results are expressed as 
peroxidase units (P.U.). On the right cell surface and intracellular localization of mutant gB proteins by 
immunofluorescence. COS cells were transfected with plasmids encoding gB5E1N and gB5E1N∆867. At 24 h after 
transfection cells were fixed with 4 % paraformaldehyde or methanol and stained with Mab 5E1 followed by an 
anti-mouse IgG-FITC conjungate. 
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g.4.3.3 Digital micrographs of BHK cells forming syncytia after cotransfection with plasmids encoding HSV-
nsertion of restrictions sites adjacent to cysteines.  
nce, carries 10 cysteines, 
cent to C1, 
 
 
 
No gB wt-gB gB5E1N gB5E1N∆867
Fi
fusogenic glycoproteins. Cells were transfected with 80 ng of plasmids encoding wt-gH, wt-gL, wt-gD, β 
galactosidase plus wt gB or gB5E1N or gB5E1N∆867. The negative control lacked gB. 48 h after transfection cells 
were fixed with 0.2% glutaraldehyde and 0.2% paraformaldehyde in PBS and then stained with 5-bromo-4-
chloro-3-indolyl-galactopyranoside (X-Gal).  
 
 
I
gB ectodomain, after cleavage of the signal seque
herein named C1, C2, etc. The spacing between gB cysteines is one of the most 
conserved pattern across the Herpesviridae family. To generate mutants by 
homologous replacement of HSV gB sequences with HHV-8 gB sequences, we 
inserted restriction sites adjacent to cysteines. Each construct was mutated in 
two or three consecutive cysteines, as follows. C1-C3-C4, C3-C4, C4-C5, C5-
C6, C6-C7, herein named gBC1C3C4, gBC3C4, gBC4C5, gBC5C6, gBC6C7.   
The mutations adjacent to C3 and C4 were silent. The mutations adja
C5, C6, C7 introduced the substitutions listed in table 4.3.1. With respect to the 
C5C6 mutants, two versions were generated, named gBC5VC6 and gBC5MC6, 
respectively. They substitutions they carry are listed in Table 4.3.1. The mutants 
gBC1C3C4, gBC3C4, gBC4C5, gBC5C6, gBC6C7 were characterized with respect to their 
ability to be expressed at the cell surface and to be mediate cell-cell fusion. The 
results are summarized in Table 4.3.1 and shown in Fig. 4.3.4 and 4.3.5. Briefly, 
none of the mutants was hampered in cell surface expression. Except gBC5VC6, 
none of the mutants was hampered in cell-cell fusion assay (Fig. 4.3.5).  
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Name  
ct 
Restriction sites Amino acid Cell surface Cell-cell 
of the 
constru
inserted substitution expression fusion 
gBC1C3C4 HindIII, XbaI, HpaI N112S + + 
gBC3C4 XbaI, HpaI Silent Mutations + + 
gBC4C5 HpaI, Asp718 
P361R, S362Y, 
V363L + + 
gBC5VC6 XbaI, XhoI 
366R, + - T365S, MI412L, G413E 
gBC5MC6 HpaI, Asp718 
 
413E + + 
P361R, S362Y,
V363L, I412L, G
gBC6C7 XhoI, EcoRV 
+ + I412L, G413E, E530D, L531I 
 
ab. 4.3.1 List of the constructs in wich restriction sites were inserted adjacent to cysteines in the ectodomain of T
HSV-1 gB. The name of the constructs refer to the number of the cysteine in mature gB, e.i. in gBC4C5 were 
added two restriction sites, one near the fourth cysteine and one near the fifth one. Cell surface expression was 
detected by immuno-fluorescence of COS cells transfected with the constructs (see fig.4.3.4). Cell-cell fusion 
assay was performed co-transfecting BHK cells with expression plasmids encoding wt-gD, wt-gH, wt-gL, plus 
listed mutated gB and pcDNA 3.1Myc-His/Lac vector (Invitrogen) for constitutive expression of β-Gal (see fig. 
4.3.5). 
 
 
 
 
 
 
 
Fig. 4.3.4. Cell surface localization of gB mutants. COS cells were grown on glass coverslips and transfected 
gB5E1N∆867 gBC1C3C4 gBC3C4 gBC4C5
gBC5VC6 gBC5MC6 gBC6C7
with plamids encoding gB5E1N∆867 or the other mutants. At 24 h after transfection the cells were fixed with 
paraformaldehyde 4% in PBS. Fixed cells were incubated for 1 h at room temperature with anti-5E1 MAb 
(1:5000), followed by anti-mouse fluorescein-conjugated immunoglobulin G (Jackson Laboratory). 
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gDHL gDHL+gB5E1N∆867 gDHL+gBC1C3C4 gDHL+gBC3C4
gDHL+gBC4C5 gDHL+gBC5VC6gDHL+gBC5MC6 gDHL+gBC6C7
 
Fig. 4.3.5 Cell-cell fusion assay. BHK cells were cotransfected with plasmids encoding wt-gD, wt-gH, wt-gL, 
β-galactosidase and gB5E1∆867 or one of the other gB mutants. The negative control lacked gB, the Erb2 plasmid 
was used to make the amounts of DNA equal. 48 h after transfection the cells were fixed with 0.2% 
glutaraldehyde and 0.2% paraformaldehyde in PBS. Syncytia were detected by light microscopy observation of 
ß-Gal expressing cells after staining with 5-bromo-4chloro-3-indolyl-ß-galactopyranoside (X-Gal). Digital 
micrograph were taken with Kodak DC120 digital camera. 
 
4.3.1.2 Generation of gB mutants by homologous replacement of HSV gB 
portions with the corresponding portions from HHV-8 gB (HSV-HHV8 gB 
chimeras).   
The strategy adopted here to generate gB mutants expected to maintain a proper 
conformation was to substitute the sequence bracketed by two (or three) 
consecutive cysteines, with the homologous sequences from HHV-8 gB (see 
alignment in Fig.4.3.6). Indeed, preliminary modelling studies, performed using 
the SWISSMODEL server (http://swissmodel.expasy.org//SWISS-
MODEL.htm) indicated that the homologous replacement mutants generated 
below can be modelled on HSV gB structure with high confidence score.  
The homologous replacement mutants were named according to the cysteines 
that bracketed the substituted region, followed by H8, which stands  for HHV8. 
To exemplify, in the mutant named gB13H8, the C1-C3-bracketed region was 
replaced with the corresponding HHV-8 C1-C3-bracketed region (see Fig 4.3.7).  
Briefly, the mutants were generated as exemplified here for gB13H8. First HSV 
gB was cleaved with the HindIII and XbaI restriction endonucleases for which 
the sites were inserted, adjacent to C1 and C3. An amplimer was generated on 
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MTK EVDEMLRSEYGG SDA N YPLSRV GK ATA LAL TFPRSIQTTHED ANE P VAN-FT TS T
HHV-8 gB template. The primers carried the HindIII and XbaI restriction sites 
useful for insertion. The digested amplimer was ligated to HindIII-XbaI 
predigested gB. All mutants were sequenced for accuracy. 
 
 
Fig.4.3.6. Amino acid sequences of HSV-1 and HHV8 gBs were aligned. The residues of the two ecodomains 
are in bold letters. Identical residues are red except for cysteines that are all green. Homologous residues are 
blue. The squares indicate the positions of the inserted restriction sites thus in some cases the amino acids 
mutated. 
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5E1
68 76
Ectodomain TMSignal seq.
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gB5E1∆867
gB34H8
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531
Zone not crystalized
Crystal domain I
Crystal domain III
Crystal domain IV
Crystal domain V
Zone not solved
5E1 epitope
Crystal domain II Sequences from
HHV8-gB  
Fig. 4.3.7 a) Schematic representation of HHV8 gB. b) Schematic representation of gB5E1N∆867 and HSV-HHV8 
chimeras. Crystal domains are depiticted in the same way used by authors of the HSV-gB solved structure [84], 
for detail see the legend at the bottom. In HSV-HHV8 chimeras are indicated the residues from HHV8 gB in 
blue and the position of the insertion in HSV-gB in black. The residue positions are ever referred to that of wt-
gB and not gB5E1∆867. 
 
4.3.1.3 Characterization of HSV-HHV8 gB chimeras.   
The HSV-HHV8 gB chimeras generated above were characterized with respect 
to  
(i) cellular localization, as detected by IFA 
(ii) Cell-cell fusion  
(iii) Infectivity complementation 
(iv) Complex formation with gD and gH, detected by pull-down experiments. 
(i) For all mutants, the chimeric gB failed to localize at the cell surface. In 
permeabilized cells, the distribution appeared to be reticular, typical of 
endoplasmic reticulum ( Fig 4.3.8) 
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(ii) All mutants failed to induce cell-cell fusion when cotransfected with gD, 
gH, gL, a results consistent with the lack of cell surface expression (Fig 
4.3.9). 
(iii) All mutants failed to mediate virus infection, as measured in a virus 
infectivity complementation assay (results not shown).  
(iv) As illustrated above, the model of HSV entry into the cell that is being 
probed in our laboratory envisions that gD forms complexes with gB and 
gH.gL. here we tested the ability of HSV-HHV-8 gB chimeras to form 
complexes with gD and/or with gH.gL. Rather than studying complex 
formation by co-immunoprecipitation studies, here we developed a pull-
down approach, as follows. The One-strep-tag sequence (IBA) was 
engineered at the C terminus of gD (gDstrep) or of gH (gHstrep). 293 
cells were transfected with gDstrep, one of the gB chimera, gH.gL. 
Alternatively cells were transfected with gD, one of gB chimera, 
gHstrep, gL. Replicate cultures were transfected with mixtures of three 
glycoproteins, rather than of four glycoprotein, in order to highlight the 
ability of the glycoporteins to give rise to interaction, even in the absence 
of some partners. Twenty four h after transfection, cells were lysed with 
detergent containing buffer (EA1+), centrifuged. The supernant was 
cleared through a ProteinA-sepharose resin, and absorbed to strep-Tactin 
resin. The absorbed proteins were eluted with SDS-containg sample 
buffer and separated by SDS-PAGE. The proteins were identified by 
western blotting. In this assay, if gDsrep (or gHstrep) forms complexes 
with the other glycoproteins, the complexes are retained by the resin, and 
subsequently, visualized by WB. Examples of the results obtained are 
shown in Fig. 4.3.9 and 4.3.10. The results worth of note were as 
follows, (a) all gB chimeras were capable to form a complex with gD, 
both in the absence and in the presence of gH. (b) some of the gB 
chimeras were capable to form a complex with gH. The exceptions were 
gB34H8 and gB45H8. This result identified the HSV gB region 
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bracketed by C3-C5 as putative region of interaction between gB and 
gH. 
gB13H8 gB34H8
gB45H8 gB56H8 gB67H8
gB5E1N∆867
 
Fig.4.3.8 Cellular localization of HSV-HHV8 chimeras. Cells were  transfected with plasmids encoding 
gB5E1N∆867 or HSV1-HHV8 gB chimeras. 24 h after transfection cells were fixed in paraformaldehyde or 
methanol and stained with MAb 5E1 followed by anti-mouse-FITC conjugate. HSV1-HHV8 gB chimeras were 
not detectable in not permeabilized cells (not shown). All micrographs show permeabilized cells. 
 
gDHL+gB5E1N∆867 gDHL+gB13H8 gDHL+gB34H8
gDHL+gB45H8 gDHL+gB56H8 gDHL+gB67H8
 
Fig.4.3.9 Digital micrographs of BHK cells submitted to cell-cell fusion assay. BHK cells were transfected with 
80 ng of plasmids encoding wt gH, gL, gD, β galactosidase plus gB5E1N∆867 or HSV1-HHV8 gB chimeras. 48 h 
after transfection cells were fixed with 0.2% glutaraldehyde and 0.2% paraformaldehyde in PBS then stained 
with 5-bromo-4-chloro-3-indolyl-galactopyranoside (X-Gal). 
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Transfected gDSTREP or wt-gD + HVEM + gHV5 + 
gLV5 + gB5E1N∆867 or HSV-HHV8 chimeras
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Fig.4.3.9  293T cells were cotransfected with plasmids that express wt-gD or gDSTREP, HVEM, gB5E1ND867 or 
HSV-HHV8 gB chimeras, and (only in a)) gHV5 and gLV5. After 24 h the cells were lysed. Expressed proteins 
present into lysates were  analysed by Western blotting (right panel, ‘Lyates’). Lysates were centrifuged and the 
supernatants were incubated prior with ProteinA-Sepharose and then with Strep-Tactin Resin. The proteins 
bound to the beads were analysed by Western blotting (left panel, ‘pull down’). To detect gD was used MAb 
H170, to detect gB5E1ND867 or gB chimeras MAb H1817 and to detect gHV5 and gLV5 anti-V5 antibody 
(Invitrogen). The negative control was the pull down in the absence of proteins with a Strep-tag (first lane). All 
HSV-HHV8 gB chimeras were recruited by gDSTREP. both in the presence (a)) and in the absence (b))of gH.gL.  
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Transfected gHSTREP + gLV5 + wt-gD + HVEM
gB5E1N∆867 or HSV-HHV8 chimeras
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Fig.4.3.9  293T cells were cotransfected with plasmids that express gHSTREP or gHV5, gLV5, gB5E1N∆867 or HSV-
HHV8 gB chimeras, and (only in a)) wt-gD and HVEM. After 24 h the cells were lysed. Expressed proteins 
present into lysates were  analysed by Western blotting (right panel, ‘Lyates’). Lysates were centrifuged and the 
supernatants were incubated prior with ProteinA-Sepharose and then with Strep-Tactin Resin. The proteins 
bound to the beads were analysed by Western blotting (left panel, ‘pull down’). To detect gD was used MAb 
H170, to detect gB5E1N∆867 or gB chimeras MAb H1817 and to detect gHV5 and gLV5 anti-V5 antibody 
(Invitrogen). The negative control was the pull down in the absence of proteins with a Strep-tag (first lane). The 
chimeras named gB34H8 and gB45H8 were recruited by gHSTREP. at a lower amount than other chimeras or 
gB5E1N∆867 both in the presence (a)) and in the absence (b))of gD and HVEM.  
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4.3.2 CONCLUSIONS 
In the past, there have been numerous efforts from a number of laboratory to 
identify functional regions in gB. The efforts included random linker insertion 
throughout the gB ectodomain, or site directed mutagenis of predicted helical 
regions. The vast majority of the studies were carried out prior to resolution of 
the crystal structure. All these studies were marred by the afct that it was not 
known whether the mutants maintained the structure of the wt allele. The 
strategy adopted here to obviate these problem was (i)conservation of conserved 
cysteines; (ii) homologous substitutions of HSV gB portions with allelic gB 
regions from HHV-8. Despite this conservative strategy, the mutants failed to be 
transpoerted to the plasma membrane, and were retained in ER. This property 
suggests problems in proper folding. Lack of transport to the cell surface has 
made it impossible to characterize the mutants with respect to their fusion ability 
in the cell-cell fusion assay.  
A most novel property of gB investigated here has been the ability of gb to form 
complexes with the ther glycoproteins required for HSV entry into the cells, 
namely gD and gH.gL. The conservative strategy applied here has indeed lead to 
the identification of a gB region most likely involved in the interaction with 
gH.gL, or critical to complex formation. The region is the segment bracketed by 
C3-C5. Inspection of gB crystal structure shows that the C3-C5 segment is part 
odf domain I, the domain that carries the candidate fusion loop of gB. Such 
candidate fusion loop appears to be critical for gB interaction with cell 
membranes.  Much of the uncertainties in interpreting these data stems from the 
fact that the soved gB structure very likely represents the post-fusion structure.  
For the ebst known viral fusion glycoproteins, it is known that the higly 
hydrophobic fusion peptide is masked when the glycoprotein adopts a prefusion 
conformation, and is expsed when the glycoprotein adopts a post-fusion 
conformation. This leads us to speculate that the possible interaction between gB 
fusion loop and gH may exert the effect of masking the fusion loop, when gB 
adopts the prefusion conformation.  
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